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Abstract 
Chronic musculoskeletal pain results in significant personal, economic, and social burden. 
Early identification and intervention in those people with acute pain that are likely to 
transition into a state of chronicity can prevent the onset of chronic pain before it emerges 
and becomes resistant to treatment. This study investigated the potential stress biomarkers 
associated with acute pain and disability and how those associations are influenced by early 
life adversities.  
Stress level was determined according to the plasma level of stress biomarkers (cortisol, 
BDNF, TGFB1) and self-report measures of stress following musculoskeletal traumatic 
events. The magnitude and direction of associations of cortisol and BDNF with self-
reported stress markers provided supportive evidence for further exploration of cortisol and 
BDNF as acute stress biomarkers. The results of the study also supported the moderating 
role of adverse childhood experiences on the associations between self-reported distress 
and stress biomarkers. 
Keywords 
Chronic pain, acute musculoskeletal trauma, Hypothalamic-Pituitary-Adrenal axis (HPA 
axis), stress biomarkers, Cortisol, Brain-derived neurotrophic factor (BDNF), 
Transforming growth factor beta1 (TGFB1), early life adversity. 
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Chapter 1  
1 Introduction 
The main rationale of this thesis is based on the multidimensional (biological, 
psychological and social) conceptualizations of chronic pain. Understanding the effects of 
the bio-psycho-social variables and their associations in the development of chronic pain 
could help clinicians to identify the patients who are likely at risk of developing chronic 
pain related conditions after having a non-catastrophic musculoskeletal injury.  Early 
recognition of the people who are at high risk could help clinicians to offer adequate and 
appropriate patient care. This could in turn reduce what can amount to enormous suffering 
and cost related to chronic pain conditions. To aid in the understating about the complex, 
multifactorial nature of chronic pain, this chapter provides an overview of the suggested 
mechanisms that are involved in the development of chronic pain. It starts by exploring the 
personal, social and financial impacts of chronic pain. The possible role of stress markers 
in the acute pain setting and how it can shape the development of chronic physical and 
psychological conditions are also discussed. The possible moderating effects of adverse 
childhood experiences on the associations between stress biomarkers and pain-related 
cognitions are also included in this chapter.  
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1.1 Prevalence and significance of chronic musculoskeletal 
pain 
The personal and social burden of chronic pain is increasingly being recognized. Chronic 
non cancer pain is the most common sequela of non-catastrophic musculoskeletal injuries. 
The International Association for the study of pain defined chronic pain as persistent or 
periodic pain experienced almost every day for a period of about six month (Phillips, 2009). 
In many cases the onset of that pain can be traced back to a trauma such as a sports injury, 
a workplace injury, aging, a car crash, surgery or even a chronic condition, such as arthritis 
or diabetes. About 1 in 5 individuals in Canada live with some forms of chronic pain 
(Moulin, Clark, Speechley, & Morley-Forster, 2002) and pain accounts for 80% of all 
physician visits (Gatchel, Robert J.; Peng, Yuan Bo; Peters, Madelon L.; Fuchs, Perry N.; 
Turk, 2007). Current best estimates following acute traumatic neck pain indicate that about 
50% will continue to report persistent problems even after 1 year (Carroll et al., 2008). The 
economic impact of chronic pain is larger than other health conditions as disability tends 
to peak in middle age, adversely affecting adults during their peak productivity years 
(Gaskin & Richard, 2012; Phillips, 2009). It is estimated that the cost of chronic pain in 
North America ($560 to $635 billion) is greater than the costs of heart disease ($309 
billion), neoplasm ($243 billion) and diabetes ($127 billion) (Gaskin & Richard, 2012 ; 
Gatchel, McGeary, McGeary, & Lippe, 2014).  
"Chronic Pain" is considered as one of the major public health problems of the 
industrialized world (Gatchel et al., 2014). Approximately 60% of people in Canada who 
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are diagnosed with chronic pain eventually lose their job (Lynch, 2011). In Sweden the 
loss of production due to absence from work as a result of chronic pain accounts for 91% 
of the total socioeconomic costs (Phillips, 2009). A study by Dennis (2006) reported about 
1 million cumulative days of sick leave annually in Denmark as a result of chronic pain 
(Eriksen, Sjøgren, Bruera, Ekholm, & Rasmussen, 2006; Phillips, 2009). In Canada, the 
mean sick leave due to chronic pain is 28.5 days per year (Phillips, 2009; Lynch, 2011). A 
Canadian study (STOP-PAIN) estimated direct (drug treatment) and indirect costs (lost 
labor time) relating to chronic pain and it was $1,462 per patient per month in Canada 
(Guerriere et al., 2010).   
Much of this burden is due to the high level of activity limitations among people with 
chronic musculoskeletal pain. Chronic pain is a "silent epidemic" as there is too little 
awareness of the real prevalence of chronic pain and it is impossible to count the costs of 
reduced quality of life, job loss, ineffective and inadequate management of pain and 
increased rates of mental disorders (Sessle, 2012). However the problem is not confined to 
the economic burden. It can also lead to enormous suffering and reduced quality of life. 
Chronic pain and musculoskeletal disorders have been associated with poorest quality of 
life indices (Sprangers et al., 2000).Several studies have found that health related quality 
of life (HRQL) in patients with chronic non cancer pain is within the lowest range when 
compared to their age and sex matched healthy controls. In a study of over 150 patients 
attending a chronic pain clinic in Denmark, there were markedly  reduced Medical 
Outcome Study- short form (SF- 36), Psychological General well-being Scale (PGWB), 
Hospital Anxiety and Depression Scale (HADS) scores in patients with chronic pain 
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compared to normal population which are indicative of major physical, social and 
psychological impairments (Becker et al., 1997).People with chronic musculoskeletal pain 
report worse  health related quality of life in comparison to patients with end-stage cancer 
(Fredheim et al., 2008). Researchers have shown that chronic pain can lead to depression 
and other mood disorders, sleep disturbances, chronic fatigue syndrome and overall 
decrease in physical and mental functioning (Ashburn & Staats, 2017;Phillips, 2009). A 
survey conducted on 85,088 people from Europe, USA, Africa, Asia and  the Middle East 
found that people with a history of chronic neck or low back pain had 2.3 times higher odds 
for mood disorder, 2.2 times more for anxiety disorders and 1.6 times more odds for 
developing substance abuse disorder in comparison with people who did not endorse any 
chronic pain symptoms (Demyttenaere et al., 2007). It is alarming that the rate of 
committing suicide is much higher among chronic pain patients compared to the general 
population. Suicide rates remain significantly higher even when mental disorders are 
controlled (Lynch, 2011). 
The problem of chronic pain is compounded by consistent findings that there are no 
obvious findings on routine diagnostic imaging that can explain the pain symptoms. This 
has led to experiences of stigma, scrutiny and alienation amongst many dealing with 
chronic pain (Rhodes, McPhillips-Tangum, Markham, & Klenk, 1999). 
Despite the high prevalence, there is by comparison relatively little guidance to support 
treatment decisions available to clinicians. The mechanisms to explain the progression to 
chronic pain after an acute musculoskeletal traumatic event also remain elusive. It is 
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necessary to develop more integrated and explanatory pathways to predict and prevent the 
development of chronic pain. 
1.2 Available treatment resources of chronic pain 
Proper diagnosis and management of chronic pain still remains ambiguous. Several 
treatment options have been evaluated for the management of chronic pain including 
pharmacotherapy (Rosenblum, Marsch, Herman, & Russell, 2008), psychological therapy 
(Eccleston, Morley, & Williams, 2013) and physical therapy (Alami et al., 2011). However 
no one approach alone proves to serve the best in terms of chronic pain management as the 
development of chronic pain from acute trauma is not straightforward or well defined. 
Available evidence on non-pharmacological approaches to chronic pain generally indicate 
a small effect (Teasell et al., 2010a). Even many of the pharmacological agents provide 
temporary relief of pain and small effects and there are controversies regarding the 
effectiveness, safety and abuse liability of long term use of those agents (Rosenblum et al., 
2008;Chang & Compton, 2013). Despite some progress in creating opioids with lower 
abuse potential, scientific and anecdotal evidence of fatal consequences from chronic 
opioid use remain (Centre for Addiction and Mental Health Prescription opioid Policy 
Framework -Canada, 2016). 
Several reasons have been cited for the long term sufferings of people with chronic pain 
such as poorly equipped pain clinics with long wait lists, under diagnosis of the problem 
and lack of knowledge regarding the mechanisms to explain the development of chronic 
pain (Lynch, 2011). 
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The introduction of the biopsychosocial model in the management of chronic pain offered 
several breakthrough clinical approaches (Gatchel, 2013). According to this model the 
development of chronic pain is the result of complex interactions between biological, 
psychological and environmental factors (Gatchel et al., 2013). This multidimensional, 
well accepted model has suggested that managing chronic pain through biological or 
psychological means in isolation was not sufficient to prevent the progression from acute 
to chronic pain or to improve outcomes in chronic pain. Rather clinicians should focus on 
the tailored approach based on individual's specific needs (Gatchel et al., 2014; Sessle, 
2012). Although there have been some improvements in our understanding of the 
mechanism of chronic pain, considerable gap in knowledge regarding clarifications of the 
mechanisms, etiology, and pathogenesis of most chronic pain conditions still exist.  While 
the relationships between biological markers and acute self-reported psychological distress 
was explored to some extent by prior research studies, the environmental and social 
counterpart of this model received relatively less attention (Sessle,2012). One of the 
motivations of this thesis is to achieve a deeper understanding of the rich interactions 
between biological, psychological and social factors that will help to improve the current 
treatment for acute, and by extension, chronic pain. 
1.3 Prognostic factors in the development of chronic pain 
following acute trauma 
Recent efforts in the field of chronic pain research have endorsed an approach of early 
identification and intervention in those people with acute pain that are likely to transition 
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into a state of chronicity, attempting to prevent the onset of chronic pain. Numerous 
psychosomatic investigations have dealt with the etiology and dynamics of chronic pain 
syndromes. A growing body of literature has agreed that the development of chronic pain 
involves complex and dynamic interactions of biological, psychological and environmental 
factors (van Hecke, Torrance, & Smith, 2013; McLean, Clauw, Abelson, & Liberzon, 
2005). However the exact mechanism that can explain the development of chronic pain 
after an acute episode is not yet fully understood. A number of models or frameworks have 
been developed to attempt to explain the reasons why a subset of people experience 
persistent pain following an acute traumatic event while the majority of patients recover. 
Different pain models explored several risk / prognostic factors that include biological, 
cognitive and environmental elements (Walton & Elliott, 2017;  Leeuw et al., 2007; 
McLean et al., 2005). Currently the best available evidence indicates that the most 
consistent predictors of chronic pain are largely cognitive in nature, including high ratings 
of pain intensity or disability, fear, catastrophizing, and low expectations of recovery 
(Walton et al., 2013a). However, recent large pragmatic clinical trials intended to 
specifically target negative cognitions have found no added benefit over a single session 
of advice and education or standard treatment (Lamb et al., 2012; Jull, Kenardy, Hendrikz, 
Cohen, & Sterling, 2013). While it would seem that a propensity to rate the experience as 
more terrible or distressing in the acute stage of injury is temporally associated with longer 
term outcome, the results of these intervention trials would suggest the mechanisms to 
explain these associations are not yet understood. It is worth exploring the knowledge gaps 
regarding acute stress markers and to integrate biological, psychological and social markers 
to identify major intervention targets. 
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The following section will provide a detailed overview of the acute stress markers and their 
potential roles in the progression from acute pain to chronic pain conditions. 
1.4 Stress markers 
This section provides an overview of the different biological, psychological and social 
stress markers that have been proposed by previous researchers to explain the possible 
mechanism of chronic pain development. The proposed role of those biomarkers in various 
stress related maladies are also discussed. At first, a brief description of "stress" in general 
is provided.  
1.4.1 Stress 
The term "Stress" was introduced by Selye (1936) as the body's nonspecific adaptive 
response to any demand. He compared stress reaction with alarm process that warns us 
about imbalance in homeostasis. According to McEwen (2003) a stressor is a real or 
implied threat to homeostasis. Stressors can be pleasant or unpleasant; real or perceived;  
physiological or psychological (H Selye, 1936; Selye, 1973; Russell et al., 2012). Selye 
(1973) gave an example to clarify the idea of stress. When a mother realizes that her son 
has some devastating disease, she experiences emotional stress that may require a shift in 
what she considers ‘normal’ to cope with the perceived threat. If she finds later that the 
diagnostic report was wrong and her son is completely fine that incident of extreme joy is 
also considered as a stress in that it leads to another shift in homeostatic status to another 
state of ‘normal’. In these two situations the stressors are completely different yet their 
response could be exactly same. In order to re-establish the normal environment, our body 
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produces several reactions. However, if the exposure to the stressors continues for a 
prolonged period of time the stress response becomes maladaptive which has been 
associated with various pathophysiology including chronic musculoskeletal pain (Louw, 
Diener, Butler, & Puentedura, 2011; Poleshuck et al., 2009), Post traumatic stress disorder 
(McFarlane, Atchison, & Yehuda, 1997), Fibromyalgia (Gupta & Silman, 2004), Diabetes 
(Byung-Wan et al., 2010), Depression (Yehuda, Halligan, Golier, Grossman, & Bierer, 
2004), Cardiovascular disease (Schwartz et al., 2015; Dimsdale, 2008) and poor pregnancy 
outcome (Latendresse, 2009). The maladaptive stress pathway and its role in the experience 
of acute pain will be explored in this research. 
1.4.2 Biological stress markers 
When the human body encounters a real or perceived threat to homeostasis it activates a 
complex range of responses including endocrine, metabolic, nervous and immune systems. 
Activation of the stress response ensures survival in the presence of adverse stimuli. One 
common pathway is activation of the autonomic nervous system (ANS). It provides a rapid 
response through both sympathetic and parasympathetic systems. Sympathetic system 
response is referred to as  the classic "fight, flight or freeze" response (Canon, 1929). 
Neurotransmitters that are released by the neurons of ANS are epinephrine, norepinephrine 
and acetylcholine (McCorry, 2007). Sympathetic adrenomedullary circuit, noradrenergic 
neurons and parasympathetic system also have role in body's adaptation process (S. M. 
Smith & Vale, 2006). These responses include some physical and psychological 
phenomena such as increased  blood flow to the muscle, increased cardiovascular tone, 
increased blood pressure, increased blood sugar and fat deposition to order to supply the 
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body with extra energy, the blood clotting system speeds up to prevent extra blood loss, 
increased muscle tension to provide extra speed and strength, increased respiratory rate, 
increased awareness, improved cognition and euphoria, decreased feeding and appetite 
(Carrasco & Van De Kar, 2003; Smith & Vale, 2006; McCrory, De Brito, & Viding, 
2010;Canon, 1929). 
One of the objectives of this thesis was to explore the role of biological stress markers in 
acute post-traumatic pain. Three stress biomarkers were specifically explored in my study, 
namely cortisol, brain-derived neurotrophic factor (BDNF), and transforming growth 
factor beta1 (TGFB1) owing to their recognized involvement in stress pathways. The 
detailed descriptions of these three biomarkers are discussed in the following sections. 
1.4.2.1 Cortisol 
General description and mechanism of action: 
Cortisol is a steroid hormone that is essential for maintaining homeostasis of the human 
body. Removal of the adrenal gland from body can be fatal if glucocorticoid is not 
administered externally (McEwen, 2006; McEwen & Wingfield, 2003). 
The main three glands that play a vital role in the initiation of the stress response are the 
paraventricular nucleus of the hypothalamus, the anterior lobe of the pituitary gland and 
the adrenal gland. Collectively they are known as Hypothalamic- Pituitary -Adrenal (HPA) 
axis. The HPA axis is the major stress system pathway in humans (Carrasco &Van De Kar, 
2003; Hans Selye, 1973; Smith & Vale, 2006; Tsigos & Chrousos, 2002). Upon 
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encountering a hostile environment or threat, the HPA neuroendocrine cascade initiates the 
release of corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) in the 
hypothalamus. Hypophysiotropic neurons of the paraventricular nucleus of the 
hypothalamus synthesize and secrete CRH. CRH binds with the corticotrophin-releasing 
hormone receptor-1 (CRHR1) and stimulates the anterior pituitary gland to release 
adrenocorticotrophic hormone (ACTH) into the systemic circulation.  ACTH binds with 
the melanocortin type 2receptor (MC2-R) in the adrenal cortex and acts on the Zona 
fasciculata. Zona fasciculata is the second of the three layers of the adrenal cortex, in order 
they are Zona glomerulosa, Zona fasciculata and Zona reticularis. This binding action to 
the mid layer of the adrenal gland triggers the synthesis and secretion of glucocorticoid 
(cortisol in primates and corticosterone in rodents). Glucocorticoids play a prominent role 
to regulate the magnitude and duration of HPA axis activation. Glucocorticoid acts on the 
hypothalamus and pituitary to suppress CRH and ACTH production in a negative feedback 
cycle, thus downregulating these hormones once the stressor has been eliminated (Tsigos 
& Chrousos, 2002; Smith & Vale, 2006;Tasker & Herman, 2011; Rivier & Vale, 1983; 
McEwen & Wingfield, 2003). This negative feedback loop is essential to ensure the return 
of the HPA axis to homeostasis when the organism is no longer challenged (Canon, 1929). 
Cortisol is a potent glucocorticoid hormone and a key biomarker of HPA axis which 
received considerable attention in biomedical and clinical research. The HPA axis not only 
promotes adaptation to stressors, but also leads to pathophysiology when it is dysregulated. 
One of its many functions is to stimulate gluconeogenesis (production of glucose) in the 
early hours of fasting. Cortisol also aids in the metabolism of fat, protein and carbohydrate. 
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Cortisol prevents sodium loss from the cells and accelerates the rate of potassium excretion, 
helping to regulate the body's PH balance. Cortisol also prevents the release of pro-
inflammatory cytokines from macrophages, helper T-cells and related immune cells that 
promote inflammation. While exposure to a stressor results in release of certain 
inflammatory cytokines namely Tumor Necrosis Factor (TNF), IL-1b, and IL-6, HPA axis 
activity and cortisol suppress the further release of these pro-cytokines (Tian, Hou, Li, & 
Yuan, 2014). However, several studies reported higher level of pro-inflammatory 
cytokines in chronic stressful conditions (Wolkow, Aisbett, Reynolds, Ferguson, & Main, 
2015; Tian et al., 2014). It has been proposed that chronic stressful condition results in 
glucocorticoid receptor resistance (GCR). GCR is responsible for up regulation of 
inflammatory cytokines which can lead to serious health consequences (Cohen et al., 
2012). 
The influence of stressful conditions on cortisol production and its proposed role in the 
development of several pathological conditions including chronic pain: 
The features of  dysregulated HPA axis function includes fatigue, malaise, abnormal 
metabolism, impaired sleep and the presence of widespread  pain which are also the main 
characteristics of several chronic pain disorders (Chrousos, 2004). This was one of the 
main reasons for which cortisol received much attention in chronic pain research.  
Animal studies have proposed the role of HPA axis dysfunction in the development of 
chronic pain and inflammation. Persistent stress has been cited as the main reasons for the 
HPA axis dysregulation in most animal studies (Tanriverdi, Karaca, Unluhizarci, & 
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Kelestimur, 2007). For example, rats that were exposed to stressful conditions during 
pregnancy via application of a stressor such as restraint or dexamethasone injection gave 
birth to offspring with increased basal plasma corticosterone level (Blackburn-Munro, 
2004). Maternal separation for 6 hours daily throughout the first 3 weeks of life resulted in 
a hypercortisolism state in animal studies (Plotsky & Meaney, 1993; Blackburn-Munro, 
2004). In human studies, the possible dysregulation of HPA axis after stressful events and 
the development of pathological conditions continue to be examined. Although there are 
sufficient evidence to support that cortisol is implicated in the pathophysiology of different 
pain related disorders, research has yet to identify the exact  mechanism involved in the 
dysregulation of HPA axis (Chrousos & Kino, 2007). 
Fibromyalgia is a common pain disorder which is characterized by chronic widespread 
pain, fatigue, anxiety and poor sleep (Tanriverdi et al., 2007). The involvement of HPA 
axis in the development of fibromyalgia has been increasingly documented by previous 
research. However, there are inconsistencies regarding the exact role of HPA axis or 
cortisol in this condition. There is evidence that in Fibromyalgia the concentration of 
circulating cortisol is increased which reflects the HPA axis dysfunction (Bote, Garca, 
Hinchado, & Ortega, 2012). However, Tanriverdi and colleagues found the opposite, a 
reduced level of plasma cortisol in a cohort of people with fibromyalgia (Tanriverdi et al., 
2007) . The alteration of HPA axis function was also documented in conditions like chronic 
pelvic pain. The associations between CPP and HPA axis dysfunction was found to be 
mediated by chronic depression (Wingenfeld et al., 2009) suggesting a possibly complex 
interaction between pain, mood, and stress activity that may explain the apparently 
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opposing findings from the fibromyalgia literature. Increased plasma cortisol was also 
observed in conditions like Chronic migraine and temporomandibular joint disorder (Peres 
et al., 2001; Korszun et al., 2002). In contrast, lower cortisol concentration was observed 
in chronic musculoskeletal pain, whiplash syndrome,  chronic fatigue syndrome and post-
traumatic stress disorder (Yehuda & Seckl, 2011; Gaab et al., 2005; Heim, Ehlert, Hanker, 
& Hellhammer, 1998; Generaal et al., 2014). Park and Ahn found lower cortisol awakening 
response (CAR)  in patients with Complex regional pain syndrome who reported frequent 
attacks of pain compared to patients who reported lower frequency of spontaneous pain 
attacks (Park & Ahn, 2012).  
From the above-mentioned discussion, it can be interpreted that the cortisol concentration 
and HPA axis activity are highly variable in previous studies. The variability in the results 
regarding cortisol and chronic pain may be due to the demographic differences of the  
participants, the methods used for the study, the stage of the specific disease, the inclusion 
of potential effect modifiers or interaction variables, and the interpretation of the results 
(Tanriverdi et al., 2007).  
Several researchers have anticipated the role of several demographic variables, early life 
stress, recent stress and social disadvantages in the alterations of HPA axis function in at 
least a subset of population (Essex et al., 2011;  Dowd, Simanek, & Aiello, 2009). All these 
factors should be evaluated while interpreting the role of cortisol in the development of 
chronic pain. There is increasing evidence that childhood adversities (e.g. experience of 
abuse, parental separation, household breakdown, loss of security) lead to persistent 
changes in the HPA axis regulation (McGowan, 2013). However, the findings are 
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inconsistent throughout the studies. Some studies suggested higher level of salivary and 
hair cortisol concentration in people who reported childhood adversities (Schreier, Enlow, 
Ritz, Gennings, & Wright, 2015). Rats who encountered parental separation showed 
increased corticosterone production. There is also evidence of increased salivary cortisol 
response in people who lost their parents in early age (Luecken, LJ  &Appelhans, 2006). 
In contrast, some studies found decreased  salivary cortisol concentration in people with 
history of adverse parenting and childhood maltreatment in compared to people who have 
not reported such adversities (Kawai et al., 2017). 
The alterations of HPA axis activity by several sociodemographic factors was also 
investigated by recent research. Lower socioeconomic status, lower income, and education 
level all have been cited as  risk factors for  the development of chronic pain conditions 
(Oliver van Hecke, Torrance, & Smith, 2013; Udom, Janwantanakul, & 
Kanlayanaphotporn, 2016). It has been proposed that the influence of these variables to the 
development of chronic pain may be mediated by the dysregulation of HPA axis activity 
(Ulirsch et al., 2015).  
Although cortisol measures have contributed much to the literature; the role of the HPA 
axis and cortisol following acute stressful event is still not well understood. To the best of 
our knowledge, this is the first study which will explore the acute reactivity of plasma 
cortisol level immediately after non-catastrophic musculoskeletal trauma. The modifying 
effects of the demographic variables and childhood adverse experiences on the acute stress 
response will also be explored to provide an insight about the mechanism of chronic pain 
development following acute traumatic event.  
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1.4.2.2 The brain-derived neurotrophic factor (BDNF) 
General description and mechanism of action: 
One of the most abundant neurotrophins of the mammalian central nervous system is 
BDNF (Li et al., 2005). BDNF belongs to the family of Nerve growth Factor (NGF) which 
promotes the survival and maintenance of brain function (Binder & Scharfman, 2004). 
BDNF is considered an essential protein that acts on the neurons of the central and 
peripheral nervous systems and helps in survival and growth of the existing neurons. It also 
ensures growth and differentiation of the new neurons and synapses (Generaal et al., 2016; 
Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz, 2015). The role of BDNF is well 
recognized in central nervous system development, maintenance and adult neuroplasticity 
which is essential for wellbeing(Carbone & Handa, 2013; M. A. Smith, Makino, 
Kvetnansky, & Post, 1995). BDNF protein is active at the connections between nerve cells 
(synapses), where cell-to-cell connection occurs. The synapses can change themselves over 
time in response to experience, which is known as synaptic plasticity. The BDNF protein 
helps regulate synaptic plasticity. Synaptic plasticity is important to maintain learning and 
memory. The brain-derived neurotrophic factor (BDNF) is one of the most studied 
neurotrophins of the central nervous system in the development and maintenance of brain 
function. BDNF plays an important role in neurogenesis, the process by which new neurons 
are developed in the brain. Previous researchers showed that  mice who were BDNF gene 
deficient suffered developmental anomalies and also died soon after birth (Kucera, Lee, 
Loring, & Jaenisch, 1995). 
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BDNF is synthesized in the endoplasmic reticulum as a small precursor protein, pro BDNF. 
Pro BDNF undergoes two cleavage steps to form mature BDNF, which remain stored in 
secretary vesicles. Upon neuronal stimulation, BDNF is released from the synapse. It binds 
with at least 2 receptors to exert its effects. One is a low affinity nerve growth factor 
receptor (commonly known as p75) and the other one is a high-affinity protein kinase 
receptor known as tropomyosin related kinase B (TrKB). The biological role of p75 is not 
clear yet. Most of the effects to maintain neuronal integrity and survival mediated by BDNF 
are thought to occur following binding to TrKB receptor (Carbone & Handa, 
2013;Daskalakis et al., 2015; Kucera et al., 1995;Barrett, 2000). 
The influence of stressful conditions on BDNF expression and its proposed role in the 
development of several pathological conditions including chronic pain: 
Brain derived neurotrophic factor disturbances and stressors have been shown to induce 
different life long adverse health consequences both independently and in interactions. 
Considerable evidence (mostly animal  studies) suggest that both the early life stress and 
recent stress has the potential to alter the BDNF expression and this can lead to various 
hazardous health consequences (Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz, 
2015; Elzinga et al., 2011).  
Although limited in numbers, studies have reported an association between BDNF 
expression and the development of chronic pain related conditions in humans. However 
the results of these studies are inconsistent. The precise mechanism underlying this 
association has not been fully understood to date. 
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It has been observed that the rats with a history of frequent maternal separation during 
childhood displayed lower BDNF level (D. Liu, Diorio, Day, Francis, & Meaney, 2000). 
This hypothesis was supported by similar findings in human studies later. Several studies  
reported lower BDNF level associated with early and recent life stressors and  lower BDNF 
level has been implicated in the development of  several negative health states such as 
depression and bipolar disorder (Elzinga et al., 2011; Fernandes et al., 2015). It has been 
proposed that altered BDNF expression along with environmental adversities may result in 
the development of depressive disorders. As the pathophysiology of depression share many 
similarities with chronic pain it was hypothesized that there may be a role for BDNF  in 
the development of chronic pain (Maletic, 2009). Moreover, BDNF appears to play an 
important role in central sensitization (Generaal et al., 2016).  Central sensitization is a 
condition in which the nervous system goes through a wind up process and gets regulated 
in a continuous state of high reactivity (Latremoliere & Woolf, 2010). Central sensitization 
is thought to be associated with fibromyalgia, low back pain, whiplash headache and 
osteoarthritis. The influential role of BDNF in the central sensitization makes it a novel 
target to prevent chronic pain development (Nijs et al., 2015).  
It is interesting to note that cortisol has emerged as an important mediator of BDNF 
expression. Recent research has shown that stress induced increase in glucocorticoid level 
leads to reduced BDNF in the hippocampus (Lakshminarasimhan & Chattarji, 2012). 
According to recent research, high BDNF and low cortisol is essential for the neuronal 
maintenance and synaptic integrity. This Glucorticoid - BDNF equilibrium should be 
maintained throughout the life in order to properly regulate stress (Daskalakis et al., 2015).  
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1.4.2.3 Transforming growth factor beta 1 (TGFB1) 
General description and mechanism of action: 
TGFB1 is a polypeptide that belongs to the cytokine family. Three isoforms exist in 
mammals (TGF-beta 1, beta 2 and beta 3). Among them, TGFB1 has widely been regarded 
as an injury related cytokine. It performs many cellular functions, including cell growth, 
cell proliferation, cell differentiation and apoptosis. It also plays an important role in the 
immune system of our body (Gomes, Sousa, & Romão, 2005). In humans it is encoded by 
TGFB1 gene. Most of the immune cells or leukocytes secrete TGFB1 and most of the cells 
have receptors for TGFB1. Hence, it is likely that this growth factor must be properly 
regulated to maintain homeostasis and prevent disease (Khalil, 1999). TGFB1 is produced 
in cells such as platelets, macrophages, B-lymphocytes and T-lymphocytes, fibroblasts, 
osteoblasts and osteoclasts, astrocytes, and microglial cells. The mechanism of regulation 
of TGFB1 is complex. TGF beta is produced in a latent form that must be activated to 
produce its biologically active form (Khalil, 1999) .  
The variation in TGFB1 expression and its proposed role in the development of several 
pathological conditions including chronic pain: 
Increase or decrease of  TGFB1 level has been found to be associated with the development 
of several chronic conditions such as chronic obstructive pulmonary disease, Rheumatoid 
arthritis, Systemic lupus erythematosus, Osteoarthritis, chronic kidney disease and 
atherosclerosis (Celedón et al., 2004; Shen, Li, & Chen, 2014; Blobe,Schiemann,& Lodish, 
2000). To date, no studies have evaluated TGFB1 in the development of chronic 
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musculoskeletal pain. Although very limited in number, few studies have suggested the 
potential role of TGFB1 in normal nociceptive pain processing as well as in the 
development of pathological pain conditions. TGFB1 has got some important 
neuroprotective effects. It has the capability to minimize the damage to the neurons 
following peripheral nerve injury (Echeverry et al., 2009; Lantero, Tramullas, Díaz, & 
Hurlé, 2012). It reduces pro-inflammatory cytokines induced nerve lesion. All these actions 
are helpful to prevent the development of neuropathic pain (Echeverry et al., 2009). 
Therefore, TGFB1 was hypothesized to have some potential role as an intervention target 
in pain management (Lantero et al., 2012). 
Mice deficient of TGFB1 showed increased neuronal cell death whereas over expression 
of TGFB1 protects against neurodegeneration in acute and chronic injury paradigm 
(Brionne, Tesseur, Masliah, & Wyss-Coray, 2003). This result is in line with some human 
studies that found the up regulation of TGFB1 following cerebral ischemia to prevent  
further neurodegeneration (Dhandapani & Brann, 2003). It has been suggested to play an 
important role to reduce the damage induced by a wide range of insulting agents including 
hypoxia, ischemia, oxidative damage etc. (Dhandapani & Brann, 2003). Therefore TGFB1 
can be an attractive candidate to explore in the acute traumatic condition to get an idea 
about the preventive strategies of TGFB1 against chronic pain development following 
acute trauma.  
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1.4.3 Psychological variants of stress markers 
The ability of psychological factors to facilitate the development of chronic pain is well 
established by resent research. The acceptance of psychological factors and their 
correlations to the onset and outcomes of acute pain episodes is increasing. Variables such 
as attitudes, perceptions, mood state, social factors and work appear to interact with pain 
behavior and are collectively called psychosocial factors. It is necessary to explore these 
psychological variables and their associations with other stress markers to understand the 
cognitive, emotional, and behavioral manifestations of pain. 
Existing evidence suggest that the most consistent psychological  predictors of chronic pain 
development are pain catastrophizing and self-reported psychological distress (Walton et 
al., 2013a; McLean et al., 2005; Quartana et al., 2010). Most of the current research has 
agreed that there is a significant relationship between excessive fear of pain or pain 
catastrophizing following acute trauma and the development of chronic pain and disability. 
Pain catastrophizing is defined as the tendency to magnify or exaggerate the threat or 
seriousness of pain sensation (Chaves & Brown, 1987). People who catastrophize become 
so overwhelmed with pain related fear or worry that they cannot distract their attention 
from pain. The overall literature suggests that exaggerated psychological responses to acute 
pain are maladaptive and likely to intensify the pain experience and delay recovery. High 
level of catastrophizing after acute trauma should be considered a risk factor for chronic 
pain development (Quartana et al., 2009; Innes, 2005). These associations can be 
understood through the fear avoidance model of chronic pain. The fear avoidance model 
of chronic pain is one of the most influential models of chronic pain development. The fear 
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avoidance model described the role of excessive fear of pain or catastrophizing and 
avoidance behavior in the progression from acute to chronic pain related conditions. In the 
acute phase of trauma, avoidance of some activities may be beneficial. However, prolonged 
avoidance of activities due to catastrophic beliefs about the pain outcome and fear of re 
injury may lead to chronicity, disuse and disability (Vlaeyen & Linton, 2012).  
Self-reported psychological distress following acute trauma was also cited as a prognostic 
factor for the development of chronic pain conditions (Walton et al., 2013a). It has been 
reported that as many as one third of people after having a traumatic event experience some 
forms of psychological distress (Innes, 2005). Despite a growing body of literature 
suggesting the role of psychological factors in the development of chronic pain, these 
factors are not completely understood and evaluated following acute traumatic events. The 
association of dysregulated HPA axis function in the development of psychological distress 
and pain catastrophizing was supported by recent research(Walton, Macdermid, Russell, 
Koren, & Uum, 2013). Inclusion of psychological and physiological stress markers is a 
unique aspect of my research study.   
1.4.4 The influence of social stress markers (early life adversities) 
on the development of chronic pain conditions 
Research studies have predominantly focused on the effects of adverse childhood 
experiences as it has emerged as an important indicator of adult health and wellbeing (De 
Bellis & Zisk, 2014; Vincent J Felitti & Anda, 2010). According to WHO World Mental 
Health Survey, physical abuse, sexual abuse and exposure to family violence was reported 
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by 5- 11%, 1-2% and 4-8% respondents, respectively, of  people surveyed from 21 
countries (Kessler et al., 2010). Patients with chronic widespread pain are more likely to 
report adverse childhood experiences than those who do not report such adversities 
(Davis&Luecken, 2005). In North America there is increasing evidence that abused women 
report more pelvic pain, multiple somatic symptoms and more lifetime surgeries compared 
to  non-abused women (DA, Leserman, Nachman, & Al, 1990).  
Previous researchers often mentioned the history of childhood adversities as a potential 
venue to look for to understand the development of chronic pain related conditions (Lampe 
et al., 2017; Linton, Lardén, & Gillow, 1996). Sexual abuse history has been found to be 
associated with chronic musculoskeletal pain (Linton et al., 1996). It was suggested that 
people with sexual abuse history may have diminished ability to cope with the pain. As a 
result, they reported higher level of distress and that may contribute to the persistence of 
pain (Linton et al., 1996). Several studies have reported the associations of childhood 
physical, sexual and emotional abuse and the development of fibromyalgia in adulthood 
(Häuser, Kosseva, Üceyler, Klose, & Sommer, 2011; Walker et al., 1997). Similar patterns 
of associations were reported between abuse and post-traumatic stress disorder (Lang et 
al., 2008). Elevated rates of childhood trauma were  also reported by a sample of patients 
with chronic low back pain (Linton, 1997). It has been suggested that the individuals who 
report childhood physical or sexual abuse are 4 to 5 times more likely to have chronic pain 
problems in adulthood (Linton, 1997). The high frequency of childhood abusive history 
among people with chronic pain conditions make it a potential candidate to include in the 
routine assessment of chronic pain related disorders (Linton et al., 1996). As with most 
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such relationships, the evidence is not consistent and may be confounded by recall bias. 
There is evidence that childhood sexual abuse did not have any role in the development of 
chronic pain (Lampe et al., 2017). Raphael et al. (2001) documented no associations 
between childhood abuse and pain in adulthood when childhood abuse history was 
determined by court documented cases. Interestingly, they found positive associations 
between abuse history and chronic pain when they used self-reported retrospective data to 
evaluate the abuse history (Raphael, Widom, & Lange, 2001). It has also been proposed 
that childhood victimization is associated only with pain of psychogenic origin rather than 
pain of clear organic origin (Adler, Zlot, Hürny, & Minder, 1989).  
It is clear from the above discussion that the results regarding the influence of childhood 
adversities on chronic pain development in adulthood are variable throughout the literature. 
Moreover, most of the studies focused on specific types of abuse (either physical or sexual) 
to explore its role in the development of chronic pain. The current thesis will explore the 
modifying role of childhood adversities (physical, sexual and emotional abuse, neglect, 
household dysfunction) on the acute stress markers.  
The existing literature regarding the relationship between childhood victimization and 
stress system regulation remain inconclusive. There is increasing evidence that childhood 
adversities lead to persistent changes in the HPA axis regulation via epigenetic mechanism 
(McGowan, 2013). Epigenetics refers to the reversible regulation of various genomic 
functions without changing the underlying DNA sequence. Rodent models have provided 
support to the idea that early life stress contribute to chronic disorders via epigenetic 
mechanisms (Moffitt & Tan, 2013). Though the idea of epigenetic plasticity is in its infancy 
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in human studies, it has been proposed that the history of childhood abuse could cause 
permanent stress system dysregulation which makes the abused population more 
vulnerable to stressors and more likely to develop chronic pain following acute trauma 
(Heim, Plotsky, & Nemeroff, 2004; McLean et al., 2005).  
Besides cortisol and HPA axis, some other biomarkers such as BDNF and TGFB1 have 
expressed themselves as potential avenue via which early life stress may influence the 
development of chronic pain conditions. A recent rodent study found epigenetic changes 
in BDNF expression in rats that experience childhood maltreatment. The study observed 
that the rats that were exposed to maltreatment by stressed caretakers showed methylation 
of BDNF DNA and which resulted in reduced BDNF gene expression in the prefrontal 
cortex. They also reported altered BDNF DNA methylation in the offspring of those 
maltreated females. Interestingly, their offspring had not been exposed to any childhood 
adversities. This may indicate the transmission of altered genes throughout generations 
(Roth, T.L., Lubin, F.D., Funk, A. J., Sweatt, 2009). In another animal study, two groups 
of primates were reared in two different conditions were examined. The group that was 
exposed to adversities in early life showed no significant correlation with cortisol following 
stressful condition in adulthood. On the other hand, the group reared in normal environment 
showed strong correlation with cortisol (Smith, Batuman, Trost, Coplan, & Rosenblum, 
2002). 
From this narrative overview of stress biomarkers, psychological markers, and early life 
adversity it can be concluded that there are several outstanding questions about the 
mechanisms underlying stress, the involvement of childhood adversities and the experience 
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of acute or chronic pain. I believe that the conflicting findings from some previous stress 
biomarker work may be due to the lack of control for potentially important social and early 
life experiences in the subjects. Also, most such work has been conducted in animals with 
relatively little done in humans under natural conditions.  However, the promising results 
of these animal studies indicate that they are worthy to explore in human studies too. As a 
preliminary step to unfold the mechanism by which abuse affects chronic pain, the current 
study will explore the associations between pain, psychological distress, physiological 
biomarkers, and early life adversities in a sample of people following acute 
musculoskeletal trauma.   
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Chapter 2  
2 Methodology 
2.1 Introduction 
Chronic musculoskeletal pain has been described as a "silent epidemic" of the modern, 
civilized world (Sessle, 2012). It is the most common cause of severe long term physical 
disability and is frequently accompanied by psychological co-morbidities such as 
depression, distress or anxiety (Bair, Robinson, Katon, & Kroenke, 2003). Chronic pain 
affects millions of people around the world. It has been estimated that one of every five 
North American adults has chronic pain at any one time (Moulin et al., 2002)and pain 
accounts for 80% of all physician visits (Gatchel, Robert J.; Peng, Yuan Bo; Peters, 
Madelon L.; Fuchs, Perry N.; Turk, 2007). 
Several studies have shown that chronic musculoskeletal pain results in significant 
personal, economic, and social burdens. The estimated cost for chronic pain in Canada is 
$1462 per patient per month and in North America is $635 billion per year (Gaskin & 
Richard, 2012; Guerriere et al., 2010).The impact of chronic pain should not be evaluated 
in economic terms solely. Chronic musculoskeletal pain patients report worse  health 
related quality of life in comparison to palliative cancer patients (Fredheim et al., 2008). 
Despite the high prevalence, there is by comparison relatively little guidance to support 
treatment decisions available to clinicians. Current guidelines endorse the use of 
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polypharmacy in addition to non-pharmacological management including physical 
therapy, stress management strategies, and psychological interventions, but what evidence 
exists to support such approaches generally indicates a small effect (Teasell et al., 2010). 
Recent efforts in the field have endorsed an approach of early identification and 
intervention in those people with acute pain that are likely to transition into a state of 
chronicity, attempting to prevent the onset of chronic pain before it emerges and becomes 
resistant to treatment. The incidence of chronic problems following musculoskeletal injury 
has been reported to range from approximately 20 to 50% depending on the conditions 
(Kongsted, Kent, Hestbaek, & Vach, 2017; Rosenbloom et al., 2016). For example, current 
best estimates following acute traumatic neck pain indicate that about 50% will continue 
to report persistent problems 1 year later, and about 30% will report severe pain and/or 
disability (Carroll et al., 2009; Sterling, 2011). Identifying mechanisms that can explain 
the development of chronic pain has therefore been identified as a high priority research 
area by experts in the field (Walton et al., 2016).The natural progression of mechanistic 
research should then be the identification of therapeutic approaches to prevent the onset of 
chronic pain.   
Development of chronic pain is a complex interplay involving biological, psychological 
and social factors (McLean et al., 2005).  Currently the best available evidence indicates 
that the most consistent predictors of chronic pain are largely cognitive in nature, including 
high ratings of pain intensity or disability, fear, catastrophizing, and low expectations of 
recovery (Walton et al., 2013a). However, recent large pragmatic clinical trials intended to 
specifically target negative cognitions have found no added benefit over a single session 
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of advice and education or standard treatment (Lamb et al., 2012; Jull, Kenardy, Hendrikz, 
Cohen, & Sterling, 2013). While it would seem that a propensity to rate the experience as 
more terrible or distressing in the acute stage of injury is temporally associated with poorer 
outcome, the results of these intervention trials would suggest the mechanisms to explain 
these associations are not yet understood. 
Several stress biomarkers namely cortisol, Brain-derived neurotrophic factor (BDNF) and 
Transforming growth factor beta 1(TGFB1) received attention in recent biomedical and 
clinical research as having potential roles in the development of chronic pain. Cortisol is a 
steroid hormone. It is considered as the major stress hormone of the human body. It is 
produced in humans by the zona fasciculata of the adrenal cortex within the adrenal gland. 
It is released in response to any kind of stressful situation (Smith & Vale, 2006). A growing 
body of literature have  supported the hypothesis that the stress system ( HPA axis ) 
dysfunction is associated  with the pathogenesis of chronic pain following acute trauma 
(Chrousos & Kino, 2007).BDNF is a member of the neurotrophin family of the growth 
factor. Neurotrophic factors are found in the brain and the periphery(Lee & Kim, 2010). 
BDNF is an important protein that acts on the neurons of the central and peripheral nervous 
systems and helps in growth, differentiation and survival of the neurons (Generaal et al., 
2016). BDNF  has been demonstrated as a novel therapeutic target in the treatment of 
chronic pain due to its potential role in neuroplasticity and central sensitization (Nijs et al., 
2015). TGFB1 (Transforming growth factor beta 1) is a polypeptide that belongs to the 
cytokine family. It performs many cellular functions, including cell growth, cell 
proliferation, cell differentiation and apoptosis. It also plays an important role in the 
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immune system. Most immune cells or leukocytes secrete TGFB1 (Khalil, 
1999).TGFB1has shown to be involved in nociceptive pain processing. Hence,  it was 
hypothesized to have some potential role as an intervention target in pain management 
(Lantero et al., 2012). However, the exact role of cortisol, BDNF and TGFB1 in the 
development of chronic musculoskeletal pain following acute trauma continues to be 
examined. We believe that deeper understanding of the rich interactions between 
biological, psychological and social factors will help to improve the current treatment for 
acute, and by extension, chronic pain. 
Adverse childhood experiences (e.g. experiencing or witnessing abuse, early 
parentification, poverty, parental incarceration or separation) appear to be more commonly 
reported among patients with chronic health conditions and may function as an important 
moderator of the association between negative affect, stress, and recovery from subsequent 
musculoskeletal trauma in adulthood. Davis and Luecken found that  people who reported 
abusive childhood experiences are more likely to develop chronic pain conditions in their 
adulthood (Davis & Luecken, 2005). Early childhood adversity has been endorsed as a 
potentially valuable avenue for exploration in the search for mechanisms to explain the 
development of chronic conditions such as musculoskeletal pain (Linton et al., 1996), 
Posttraumatic stress disorder (Lang et al., 2008) , Fibromyalgia (Häuser et al., 2011), 
Chronic pelvic pain (Hu, Link, McNaughton-Collins, Barry, & McKinlay, 2007), and low 
back pain (Linton, 1997). Linton (1997) found that those who reported childhood physical 
or sexual abuse were 4 to 5 times more likely to have chronic pain problems in adulthood 
(Linton, 1997).  However, as with the association between negative cognitions and chronic 
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pain, the mechanisms to explain the link between adverse childhood events and the genesis 
of chronic pain remain unclear. Work from the lab of Walton and others has recently found 
that stress biomarkers (e.g. cortisol) appear to show associations with both negative 
posttraumatic cognitions and acute pain intensity, and may function to influence the course 
of recovery following trauma. To the best of our knowledge, the moderating effect of 
childhood adversities on the associations between these biological and psychological stress 
markers following acute trauma has yet to be explored. 
2.2 Purpose 
The main objectives of the study were to: 
1) Explore differences in key stress biomarkers and self-rated pain intensity in a sample of 
people with acute musculoskeletal injuries when grouped by age, sex, body mass index 
(BMI), income level, education and medication history. 
 2) Explore the associations between major stress biomarkers (cortisol, brain-derived 
neurotrophic factor (BDNF) and transforming growth factor beta1 (TGFB1)) and pain 
severity and distress in the acute setting of pain.  
3) Identify potential moderating effects of adverse childhood experiences on the 
associations between stress biomarkers and pain-related cognitions.  
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2.3 Methods and Materials 
2.3.1 Study Design 
This was a cross-sectional exploratory study.  
2.3.2 Participants 
Eligible participants were those who had experienced an acute, non-catastrophic 
musculoskeletal injury within 1 week of presenting to the urgent care centre at St. Joseph’s 
hospital (London Ontario, Canada). Participants were initially approached by their primary 
clinician (either physician or emergency care nurse) who obtained consent to be contacted 
by the research assistant for more information, full eligibility screening, and to obtain 
informed consent if they were willing and eligible to participate. Participants received 30 
Canadian dollars as compensation for their participation in this part of the study. Full 
inclusion criteria were: aged 18 years or older, able to speak and understand English, and 
presented for an acute injury affecting the musculoskeletal system that did not require 
surgery or hospitalization.  Exclusion criteria included those with cognitive impairments 
that interfered with ability to follow detailed instructions, those with neuromuscular 
disorders that impaired mobility (e.g. stroke, multiple sclerosis), any active malignancies 
within the past 5 years, and active systemic inflammatory or autoimmune conditions (e.g. 
rheumatoid arthritis, systemic lupus erythematosus). Finally, those who had been 
diagnosed with a concussion or were hospitalized overnight at any point in the prior 6 
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months, those under the influence of drugs or alcohol at the time of presentation to the 
department, or those with no fixed address were excluded from this part of the study. 
2.3.3 Procedure (sample and data collection) 
After obtaining consent, participants were provided an intake and screening form and brief 
questionnaire to gather more information at the time of presentation. Questions such as 
"Are you pregnant or lactating" or "Are you taking any antibiotics currently" were 
highlighted in the intake and screening form. The above mentioned two criteria are not 
exclusion criteria for the study. However it is helpful to know about these kinds of 
additional information to better understand the sample characteristics. Among all 
participants, single patient was pregnant. As none of the stress biomarkers were out of the 
normal reference range for that participant, they were retained for this study. Additional 
metadata were collected at that time (e.g. age, sex, current medication use, and 
pregnancy/post-partum status if applicable). Two vials of antecubital blood were then 
collected by a trained phlebotomist that were immediately stored in a clinic freezer before 
being transported to a laboratory for centrifugation and storage at -80C until extracted for 
assay.  
Participants were discharged from the department with a set of questionnaires for capture 
of more detailed experiences after the traumatic event. These questionnaires captured a 
number of constructs including additional metadata (height, weight, income, working 
status, educational status, compensation/litigation involvement), Injury specifics 
(mechanism, area injured, time since onset), and a series of standardized questionnaires 
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(described below). Participants were asked to complete the forms within 24 hours of 
discharge. 
2.3.4 Predictor (Independent) variables 
2.3.4.1 Demographic factors 
Age, sex, BMI, education, income, medication usage all these factors are used as 
independent variables to test the hypothesis of this study.  
2.3.4.2 The traumatic injuries distress scale (TIDS) 
The Traumatic Injuries Distress Scale (Walton, Krebs, et al., 2016) is a 12-item 
questionnaire designed to measure 3 different areas of trauma-related distress (negative 
affect, uncontrolled pain, and intrusion/hyper arousal) following acute musculoskeletal 
injuries. The TIDS is intended to capture affective vulnerabilities of the participants 
following acute trauma. The scale is available in 3 languages: English, French and Spanish. 
Walton and colleagues have found elevated scores on the TIDS to be associated with 
slower recovery 3 or 6 months later (Walton, Krebs, et al., 2016). 
2.3.4.3 The adverse childhood experiences questionnaire (ACE) 
The Adverse Childhood Experiences (ACE) questionnaire is a 10-item self-report tool that 
asks respondents to recall adverse events experienced in the first 18 years of life. High level 
of childhood adversities were found to be  associated with a 4 to 12-fold increased risk of 
alcoholism, drug abuse, depression and suicidal attempt; a 2 to 4-fold increased risk of 
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smoking and poor health habits; and a 1.4 to 1.6-fold increased risk of severe obesity 
(Felitti et al., 1998). This is one of the widely used instruments to explore the cumulative 
stress experienced during childhood. It has been used in pediatrics, mental health and other 
health settings (Murphy et al., 2014).  
ACE can provide retrospective reports about childhood abuse (physical, sexual and 
emotional), neglect and household dysfunctions. Each question is rated dichotomously: yes 
/ no. The ACE questionnaire has been shown to be adequately reliable and valid to identify 
potentially vulnerable individuals with childhood adversities (Murphy et al., 2014; Felitti 
et al., 1998).  In the current study, the ACE questionnaire was used to divide the data into 
two groups (one group who have endorsed at least one variety of childhood abuse and the 
other group who have not endorsed any of them). The differences between these two groups 
in the interplay between stress markers in the acute pain setting were explored. 
2.3.4.4 The acute stress disorder scale (ASDS) 
 The ASDS scale (Bryant, Moulds, & Guthrie, 2000) is a 19-item screening tool intended 
to screen for Acute Stress Disorder (ASD) using criteria defined in the Diagnostic and 
Statistical Manual of Mental Disorder (DSM-IV; 4thed; American Psychiatric Association, 
1994). The term "acute stress disorder" refers to the stress reaction that occurs within the 
first month after having a traumatic event. People with acute stress disorder are more likely 
to develop post traumatic stress disorder later in life (Edmondson, Mills, & Park, 
2010;Harvey & Bryant, 2002).  It is the most widely used self- report questionnaire  to 
diagnose "acute stress disorder" (Edmondson et al., 2010).   
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The scale comprises 5 dissociative, 4 re-experiencing, 4 avoidance and 6 arousal 
symptoms. The items are scored on a 5 point scale (1= not at all, 2=mildly, 3=medium, 4= 
quite a bit, 5= very much). The total ASDS is scored by summing the scores of all the 
items. The total ASDS score correctly identified 91% of people who developed subsequent 
PTSD (Bryant et al., 2000). Despite of having high specificity in diagnosing PTSD, it has 
showed lack of sensitivity  in PTSD diagnosis (Bryant et al., 2000; Harvey & Bryant, 
2002). 
2.3.4.5 The brief pain inventory (BPI) - short form 
The brief pain inventory (C S cleeland, 1994) is a self-administered questionnaire that was 
initially developed to measure pain in cancer patients (C S cleeland, 1994). However, it is 
also commonly used as an adequately valid and reliable measure of severity and 
interference from non-cancer pain (Tan, Jensen, Thornby, & Shanti, 2004;Keller et al., 
2004). The BPI scale is easy to administer, available in many languages and easily 
accessible (Tan et al., 2004). The BPI is very efficient in evaluating and identifying pain 
intensity and associated disabilities in patients reporting lower back pain and arthritis 
(Keller et al., 2004) and chronic non-malignant pain (Tan et al., 2004). It provides a quick 
means of measuring pain intensity and the degree to which pain interferes with living and 
general activities.  
This 11-item self-report tool includes 4 items capturing pain intensity and other 7 items 
reporting pain interference. The pain intensity subscale asks about worst pain, best (least) 
pain, and average pain over a period of about 24 hours and current level of pain to measure 
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the severity of pain. Each of the items is graded from no pain (0) to extreme pain (10) for 
a scale range of 0 to 40. The 7 items pain interference subscale assesses how pain interferes 
with activities of daily living such as general activity, mood, walking ability, work, relation 
with other people, sleep and enjoyment of life. These 7 items are anchored with "does not 
interfere" to "completely interferes" for a range from 0 to 70.  Pain interference subscale 
should be interpreted as 2 different domains -Physical interference and affective 
interference. The item demonstrating sleep interference should be interpreted separately 
(Walton, Beattie, Putos, & MacDermid, 2016). Current study used this scale to explore the 
pain intensity and pain interference scores of people who underwent a traumatic 
musculoskeletal injury. 
2.3.5 Outcome (Dependent) variables 
2.3.5.1 Cortisol 
Assay technique: 
Human plasma concentrations of cortisol were determined by radio immunoassay with a 
commercially available kit (DetectX Cortisol Immunoassay kit; Arbor Assays, Michigan, 
USA). Total cortisol was quantified according to the manufacturer's protocol. The assay 
sensitivity was ascertained at 1.73pg/mL and the limit of detection was determined as 
45.4pg/mL. The concentration of cortisol was calculated using software available with 
most plate readers. 
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2.3.5.2 BDNF & TGFB1 
Assay technique: 
Levels of brain-derived neurotropic factor (BDNF) and transforming growth factor beta 1 
(TGFB1) were measured using multiplexed biomarker immunoassay kits according to 
manufacturers’ instruction (BDNF: Human Magnetic Luminex Assay, R&D Systems, Inc., 
Minneapolis, USA, TGFB1: Milliplex MAP TGFB1 Magnetic Bead Single Plex Kit, EMD 
Millipore Corporation, Missouri, USA). A Bio-PlexTM 200 readout System was used (Bio-
Rad Laboratories, Hercules, CA), which utilizes Luminex® xMAPTM fluorescent bead-
based technology (Luminex Corp., Austin, TX). Levels were automatically calculated from 
standard curves using Bio-Plex Manager software (v.4.1.1, Bio-Rad). Plasma BDNF and 
TGBF1 protein levels were expressed in picograms per millilitre (pg/mL). 
2.4 Data analysis 
All variables were examined for missing values, outliers, normality of distribution, and 
homogeneity of variance. At first, subject characteristics (age, sex, BMI, Income, 
education) were evaluated descriptively (mean/ median, SD, range, frequency). 
Independent variables were demographic factors, baseline ASDS (total score, distress 
subscale, dissociation subscale), BPI (pain intensity subscale, pain interference subscale, 
physical interference subscale, affective interference subscale, sleep interference subscale), 
TIDS (total score, uncontrolled pain, negative affect and hyper arousal subscales) and ACE 
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(those with/without at least 1 adverse experience endorses). The dependent variables on 
the hypothesis being tested included stress biomarkers (Cortisol, BDNF and TGFB1). 
2.4.1 Handling missing values and outliers 
Where data were missing, we excluded the participant just for that analysis. Box plots and 
scatter plots were generated to identify outliers. As correlations can be influenced by 
extreme data, outliers (those that were more than 3 times the interquartile range) were 
removed from this exploratory analysis. Data were removed cautiously at this preliminary 
stage of research as outliers may indicate an interesting but rare subset of people. The rich 
dataset including metadata offered ample opportunity to scrutinize each outlying data point 
by exploring other characteristics of that participant. If that person showed proportionate 
and consistent values in other related variables that were theoretically understandable then 
that outlier was kept in the data set. 
2.4.2 Data Normality 
Shapiro-Wilk’s normality test was performed and a histogram was plotted to check the 
normality of each variable. Stress biomarker variables were positively skewed initially. To 
ensure the normality of the data square root transformation of variables were performed. 
All the dependent variables were approximately normally distributed (according to the 
Shapiro-Wilk test) after doing the square root transformation. Assumptions of normality 
were not violated for most of the variables as all the p values were more than 0.05. Normal 
Q-Q plot also indicated the normality of the data.   However due to nature of the data and 
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limited sample size normality could not be assumed for few self-reported variables. To 
ensure the robustness of the results, non-parametric tests were performed in those variables.  
2.4.3 Test for homogeneity of variance 
Equality of variance was evaluated using Levene’s test. Where it was violated, a correction 
factor was applied to avoid alpha error. 
2.4.4 Data coding 
2.4.4.1 Age 
Age was provided in years. Median age (40 years) was used as the cut-off point. 
Participants were divided into two groups according to their age; 40 or under (group =1) 
and above 40 (group =2). 
2.4.4.2 Sex 
About 25 males and 46 females completed the study. Sex was coded as: male= 1, female=2. 
2.4.4.3 BMI 
Median value (26.1) was used as the cut off point for BMI. BMI was coded as 2 groups: 
26.1 kg/m2 or under (group= 1), above 26.1 kg/m2 (group=2). 
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2.4.4.4 Medication usage  
There were 27 people who were taking anti-anxiety / anti-depressant medications at the 
time of injury and 49 people who did not provide such history. Medication history was 
coded as: not taking any anti-anxiety / anti-depression medications =0, taking anti-anxiety/ 
anti depression medications=1. These classes of drugs were considered the most relevant 
considering the primary evaluations related to post-traumatic stress and affective 
interference. 
2.4.4.5 Income 
There were 8 ranges provided in the questionnaire: < $ 20,000= 1; $20000-$40000= 2; $ 
41000- $60000= 3; $ 61000- $ 80000= 4; $ 81000- $100000= 5; $101000-$150000= 6; 
$151000- $200000= 7; >$200000= 8. Income history was coded as ≤ CDN $100,000 total 
household per year (group= 1) and income > 100,000 total household per year (group=2).  
2.4.4.6 Education level 
There were 7 levels in the questionnaire: did not finish school, high school, community 
college, trade school, university undergraduate degree, master's degree, and doctorate. 
Education was coded as Low education (group 1) = Trade school, community college, or 
no post-secondary education and High education (group 2) = university undergraduate 
degree or higher. 
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2.4.4.7 Adverse childhood experiences 
ACE questionnaire was used to determine the presence or absence of childhood adverse 
history. Total 52 people endorsed at least one component of ACE questionnaire and 22 
people indicated that they did not have such adversities in their childhood. These two 
groups were coded as 1 (who had adverse childhood history) and 0 (who did not have such 
histories) respectively.   
2.4.5 Statistical tests (Hypothesis testing) 
2.4.5.1  Hypothesis 1 
There will be a significant difference in stress markers in the acute pain setting when the 
sample is split according to age, sex, BMI, education level, income level, medication usage, 
and adverse childhood experiences. 
Stress level was determined according to the plasma level of stress biomarkers (cortisol, 
BDNF, TGFB1) and also the self-report measures of stress following musculoskeletal 
traumatic event. At first the sample is split into two groups according to age, sex, BMI, 
education level, income level, medication usage, and adverse childhood experiences. Then, 
Independent samples t-test was performed to explore differences between each group. As 
some of the self-report questionnaires were not normally distributed Mann- Whitney U-
test was used.   
43 
 
 
 
2.4.5.2 Hypothesis 2 
There will be significant correlations between biological and psychological markers of 
stress following acute traumatic events. 
Pearson's correlation coefficient (r) and Spearman's Rho (rho) were used to explore the 
correlations between biological (cortisol, BDNF, TGFB1) and psychological (TIDS, 
ASDS, BPI) stress markers in the acute pain setting. Then, multiple regressions were 
performed to find out the proportion of variance of dependent variables that could be 
explained by independent variables after controlling for any relevant confounding 
demographics identified from hypothesis1. Preliminary analyses were performed to ensure 
that there was no violation of assumptions of regression (normality, linearity, 
multicollinearity and homoscedasticity). 
2.4.5.3 Hypothesis 3 
The history of adverse childhood experiences will moderate the correlations between acute 
stress biomarkers and self-reported distress. 
To test the hypothesis about the moderating effects of adverse childhood experiences, the 
correlations between acute stress markers were generated when the sample is split in two 
groups according to the scores of the ACE questionnaire. Significant correlations between 
variables were plotted by scatter plots to visualize and compare the associations between 
ACE and No ACE groups. All statistical tests were 2-tailed tests conducted at p ≤ 0.05, 
unless otherwise indicated.  
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2.4.6 Bootstrap resampling 
 A bootstrap resampling method was used to identify the 95% confidence interval of each 
of the significant correlations. A sample size of 1000 was used to test the hypothesis.  Those 
correlation point estimates (Pearson’s r) that differed between ACE groups to an extent 
that the point estimate of one was outside the 95%CI of the other were considered 
significantly different associations. 
2.4.7 Sample size estimation 
Sample size was estimated assuming a medium effect size (Pearson’s correlations of 0.3 to 
0.5) for our primary analyses, with a desired power of 80% to observe the effect while 
accepting a 5% alpha error rate. G*power software version 3  was used for the calculation 
(Faul, Erdfelder, Lang, & Buchner, 2007). As a result, a sample size of 84 subjects was 
targeted. 
Raw data from the ongoing study were analyzed using SPSS software version 23 (IBM 
corp., USA). 
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Chapter 3  
3 Results and Discussions 
3.1 Results 
3.1.1 Sample characteristics 
Within our recruitment timeline, 76 participants completed the study. A total of 691 
patients were approached to participate of which 518 refused or were unable to comply 
with the requirements of the study. Of the remaining173 who consented in the urgent care 
department and provided blood, saliva and partial baseline data, 76 completed and returned 
all baseline data and formed the sample for this study. The breakdown of total participation 
is given below:  
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Table 3.1 provides the participant characteristics. The sample was primarily female 
(64.8%) of median 40 years of age. Modal education level was university undergraduate 
degree (28%) and 60% were employed full time. There was a bimodal distribution of 
income, where both $41,000 - 60,000 and $101,000-150,000 salary range were reported by 
24.3% of the sample. The most common etiologies were fall on level ground and being hit 
by an object (15.1% each). The modal body regions injured were ankle (25%), knee 
(13.2%) and wrist (13.2%). 
Table 3.2 provides details from the self-report tools and descriptive statistics of the stress 
biomarkers (cortisol, BDNF, TGFB1). Some of the self-report data and plasma biomarkers 
were not normally distributed. Hence, median and range are reported for them in table 3.2. 
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Table 3.1: Demographic data of participants. 
 
Characteristics Value 
Age ( median, range ) 40  (18 to 66) 
Sex (no. female %) 46 (64.8%) 
Height in meters  ( mean, range) 1.6 (1.4 to 1.9) 
Weight in kg ( mean, range) 76.2  (43.6  to 136.3) 
BMI (kg/m2) Median 26.1 
SD 5.7 
Range  15.8 to 43.6 
Total household income level per 
year ( number of people, 
percentages) 
<$20000 6 (8.1%) 
$20000- $40000 9 (12.2%) 
$41000- $60000 18 (24.3%) 
$61000- $80000 8 (10.8%) 
$81000-$100000 11 (14.9%) 
$101000- $150000 18 (24.3%) 
$150000-$200000 3 (4.1%) 
> $200000 1 (1.4%) 
Level of education  
(n (%)) 
Did not finish school 2 (2.7%) 
High school 19 (25.3%) 
Community college 15 (20.0%) 
Trade school 7 (9.3%) 
University undergraduate degree 21 (28.0%) 
Master's degree 8 (10.7%) 
Doctorate 2 (2.7%) 
Others  1 (1.3%) 
Employment status  
(n (%)) 
Full-time 45 (60.0%) 
Part-time 12 (16.0%) 
Off work due to injury 2 (2.7%) 
Not employed for pay 16 (21.3%) 
Current anti-anxiety or anti-
depressant medications history  
(n (%))  
People who were taking medications1 27 (35.5%) 
People who were not taking  medications1 49 (64.5%) 
Primary cause of the symptoms  
(n (%)) 
Motor vehicle  accident 4 (5.5%) 
Pedestrian accident 1 (1.4%) 
Fall while on the level ground 11(15.1%) 
Fall down a hill or stairs 6 (8.2%) 
Fall from a height 1 (1.4%) 
Hit by an object 11 (15.1%) 
Hit by another person( not while playing) 1 (1.4%) 
An awkward lift or twist 10 (13.7%) 
Hit by another person (while playing) 2 (2.7%) 
Part of body injured  
(n (%)) 
 
Neck 6 (7.9%) 
Shoulder 10 (13.2%) 
Elbow 4 (5.3%) 
Hand and Wrist 10 (13.2%) 
Lower back 7 (9.2%) 
Hip 1 (1.3%) 
Knee 10 (13.2%) 
Foot and Ankle 19 (25.0%) 
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1: Medications considered were anti-depressant or anti-anxiety drugs. 
 
Table 3.2: Descriptive statistics of dependent and independent variables. 
 
1. Microcomputer Software Review Enzlab - - Elsevier Biosoft Synthetic Peptides in Biology and Medicine 
Book Reviews Textbook of Clinical Chemistry, 1986 
2.Polacchini et al., 2015 
3.Kyrtsonis et al., 1998 
Tool Subscales Median (range) 
Adverse childhood 
effect questionnaire 
(ACE) 
People who have no history of early life 
adversity (29.7%) 
0 
People who endorsed at least 1 component 
of the questionnaire (70.3%) 
3 (1 to 8) 
Acute stress disorder 
scale (ASDS) 
ASDS scale (Total, median(range))  95, 26 (19 to 67) 
Dissociation subscale (Total, 
median(range)) 
 25, 6 (5 to 17) 
Distress subscale (Total, median(range)) 70, 20 (14 to50) 
Brief pain inventory- 
short form (BPI ) 
Pain intensity subscale(Total, 
median(range)) 
40, 18.5 (3 to 32) 
Pain interference subscale(Total, 
median(range)) 
70, 29.5 (3 to 67) 
Physical interference subscale(Total, 
median(range))  
30,16.5  (2 to30) 
Affective interference Subscale (Total, 
median(range)) 
30, 4(0 to 18) 
Sleep interference subscale (Total, 
median(range)) 
10, 4 ( 0 to 10) 
Traumatic injuries 
distress scale ( TIDS) 
Uncontrolled pain  subscale(Total, 
median(range)) 
8, 3 (0 to 8) 
 Negative Affect subscale (Total, 
median(range)) 
12, 2(0 to 12) 
Hyper arousal subscale(Total, 
median(range)) 
4, 0 ( 0 to 3) 
Total score of TIDS(Total, median(range)) 24,6 (0 to 17) 
Biomarkers of stress 
 
Reference range 
(pg/mL) 
Median pg/mL (range) 
Cortisol 20,000  to  2,50,0001 89,285 (21,270 to 3,59,60) 
BDNF  8000  to 46,0002 2,034.1  (422.08 to 10625.22) 
TGFB1 1000 to 33,000 3 20,313.5 (5428.9 to 59,122.7) 
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3.1.2 Hypothesis testing 
3.1.2.1 Hypothesis 1: Exploring the influence of demographic variables 
on stress markers 
Table 3.3 shows the mean differences in stress biomarkers (cortisol, BDNF, TGFB1) when 
the sample is split according to age, sex, BMI, education level, income level, medication 
usage, and adverse childhood experiences. The only significant differences were in cortisol 
(t (56) = 2.09; p = 0.04) and BDNF (t (54) = -1.92; p = 0.05) between the high and low 
BMI groups. The high BMI group showed lower cortisol (279.9 vs.329.9 pg/mL) and 
higher BDNF (52.2 vs.43.3 pg/mL) compared to the low BMI group. Differences between 
all other groups and all TGFB1 comparisons did not reach statistical significance. 
 
Table 3.3: Means (SD) of biomarkers split by key personal-level variables in the 
acute setting of pain. 
 
 
Variable 
BDNF 
(pg/mL) 
Cortisol (pg/mL) 
TGFB1  
(pg/mL) 
Age          40 or under (n = 36) 
                 Over 40 (n=35) 
47.6 (18.1) 
47.0 (19.6) 
304.1 (97.7) 
315.9 (86.8) 
146.6 (40.9) 
138.2 (37.4) 
Sex            Male (n = 25) 
                  Female (n = 46) 
47.3 (22.2) 
47.4 (16.7) 
308.7 (77.8) 
310.5 (100.2) 
132.2 (33.1) 
148.1 (41.5) 
BMI       ≤26.1 kg/m2 (n = 31) 
              >26.1 kg/m2  (n = 31) 
43.3 (15.0) 
52.2 (19.5) 
329.9 (105.7) 
279.9 (73.8) 
139.9 (40.6) 
149.4 (41.6) 
Income1          Group 1 (n = 48) 
                    Group 2 (n = 22) 
49.7 (20.1) 
44.1 (14.2) 
311.8 (96.2) 
316.5 (89.6) 
147.8 (39.6) 
139.4 (48.4) 
Meds2                    No (n = 49) 
                       Yes (n = 27) 
47.3 (18.4) 
49.8 (19.4) 
320.4 (107.7) 
299.5 (57.2) 
139.7 (41.9) 
157.2 (40.0) 
Education3         Low (n = 37) 
                       High (n = 38) 
46.3 (17.6) 
49.9 (19.7) 
316.2 (71.8) 
310.3 (112.3) 
139.0 (38.3) 
151.7 (44.5) 
ACE4                      None (n = 22) 
                   At least 1 (n = 52) 
48.8 (21.4) 
48.1 (17.7) 
293.5 (71.2) 
309.4 (80.0) 
144.3 (37.3) 
146.0 (43.8) 
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Bold: Differences between groups significant at the p ≤ 0.05 level 
1.  Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year 
Income Group 2= > CDN$100,000 total household per year. 
2: Medications considered were anti-depressant or anti-anxiety drugs. 
3: High education = university undergraduate degree or higher  
 Low education = Trade school, community college, or no post-secondary education. 
4: ACE = Adverse Childhood Experiences questionnaire. 
 
Table 3.4 includes the differences in self-report measures of stress  as measured by Acute 
stress disorder scale(ASDS) following traumatic musculoskeletal injury when the sample 
is split according to age, sex, BMI, education level, income level, medication usage, and 
adverse childhood experiences. None of the differences were statistically significant. 
 
Table 3.4: Means (SD) of scores of the Acute Stress Disorder Scale (ASDS) and 
subscales split by key personal-level variables in the acute setting of pain. 
 
 
 
1.  Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year 
Income Group 2= > CDN$100,000 total household per year 
2: Medications considered were anti-depressant or anti-anxiety drugs. 
3: High education = university undergraduate degree or higher 
 Low education = Trade school, community college, or no post-secondary education. 
4: ACE = Adverse Childhood Experiences questionnaire. 
Variable 
 
Total ASDS 
Score 
Distress 
Subscale 
Dissociation 
Subscale 
Age                        40 or under (n = 36) 
                               Over 40 (n = 35) 
26.7(8.7) 
30.3 (11.5) 
20.4 (7.2) 
22.6 (8.7) 
6.4(2.3) 
7.6 (3.4) 
Sex                         Male (n = 25) 
                               Female (n = 46) 
28.2 (11.3) 
28.6 (9.6) 
21.5 (8.8) 
21.4 (7.6) 
6.6 (2.9) 
7.2(2.9) 
BMI                        ≤  26.1 kg/m2 (n = 31) 
                               >26.1 kg/m2  (n = 31) 
26.6 (9.3) 
29.1 (9.4) 
20.3 (7.4) 
21.5(6.8) 
6.3(2.7) 
7.4 (2.9) 
Income1                 Group 1 (n = 48) 
                               Group 2 (n = 22) 
28.0 (8.6) 
30.4(13.4) 
21.3 (6.8) 
22.5 (10.3) 
6.7 (2.4) 
7.8(3.7) 
Medication2              No (n = 48) 
                                 Yes (n = 23) 
28.2 (8.7) 
29.1 (12.6) 
21.3 (7.1) 
21.8 (9.2) 
6.8(2.5) 
7.2 (3.4) 
Education3               Low (n = 35) 
                                 High (n = 35) 
27.5 (8.6) 
29.7 (11.5) 
20.7 (6.9) 
22.4 (8.7) 
6.7 (2.4) 
7.2 (3.2) 
ACE4                                     None (n = 20) 
                                 At least 1 (n = 49)  
28.7(10.4) 
28.5 (10.1) 
21.8 (8.2) 
21.4 (7.8) 
6.9 (2.9) 
7.1 (2.9) 
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Table 3.5 shows the differences in self-report measures of stress as measured by the Brief 
Pain Inventory (BPI) following traumatic musculoskeletal injury when the sample is split 
according to age, sex, BMI, education level, income level, medication usage, and adverse 
childhood experiences. The only significant difference was in pain intensity by education, 
where the low education group reported significantly higher pain intensity than the high 
education group (t (65) =2.04, p =0.04). 
 
Table 3.5: Mean (SD) of scores of the Brief Pain Inventory (short form) scale and 
subscales Split by key personal-level variables in the acute setting of pain. 
 
Variable 
Pain 
intensity 
Subscale 
Pain 
interference 
Subscale 
Physical 
interference 
Subscale 
Affective 
interference 
Sleep 
interference 
Subscale 
Age     
40 or under (n = 34) 
Over 40 (n = 32) 
 
18.4(7.3) 
17.6(7.8) 
 
28.6 (16.3) 
29.0 (16.6) 
 
16.3 (7.7) 
15.6 (7.9) 
 
4.8 (4.9) 
5.3 (4.7) 
 
3.6 (2.9) 
3.9(3.6) 
Sex            
Male (n = 23) 
Female (n = 43) 
 
18.5 (7.6) 
17.8 (7.5) 
 
30.5 (16.2) 
27.9 (16.5) 
 
15.6 (6.7) 
16.2(8.3) 
 
6.0(5.4) 
4.5(4.4) 
 
4.2 (3.1) 
3.5 (3.3) 
BMI  
≤  26.1 kg/m2 (n = 27) 
>26.1 kg/m2 (n = 27) 
 
18.0 (7.3) 
18.8 (6.6) 
 
29.3(15.0) 
30.9 (16.3) 
 
16.3(6.9) 
16.8 (7.8) 
 
5.4 (4.5) 
5.3 (4.8) 
 
3.7 (3.1) 
4.2 (3.2) 
Income1 
Group1  (n = 51) 
Group 2  (n = 18) 
 
18.4 (6.9) 
17.6 (8.6) 
 
30.8 (16.6) 
28.7(16.1) 
 
16.9 (8.2) 
15.1 (6.1) 
 
5.2 (4.8) 
5.7 (4.9) 
 
4.2(3.1) 
3.8 (3.5) 
Medication2 
No (n = 48) 
Yes (n = 24) 
 
18.6 (7.6) 
17.2 (6.7) 
 
29.4 (15.4) 
30.7 (18.5) 
 
15.9 (7.3) 
17.3(8.5) 
 
5.3 (4.5) 
4.9 (5.3) 
 
3.9 (3.1) 
4.1(3.5) 
Education3 
Low (n = 35) 
High (n = 35) 
 
20.1 (6.9) 
16.5 (7.3) 
 
33.5 (16.7) 
26.8 (15.5) 
 
18.0(7.8) 
15.1(7.3) 
 
6.1 (5.0) 
4.4 (4.5) 
 
4.5 (3.2) 
3.6 (3.2) 
ACE4 
None (n = 20) 
At least 1 (n = 49)  
 
17.3 (8.3) 
18.7 (6.9) 
 
29.0 (14.9) 
30.5(17.2 ) 
 
17.4 (7.8) 
16.2 (7.8) 
 
4.2 (3.8) 
5.7 (5.2) 
 
3.4 (3.1) 
4.3 (3.3) 
 
Bold: Differences between groups significant at the p < 0.05 level 
1.  Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year 
Income Group 2= > CDN$100,000 total household per year 
2: Medications considered were anti-depressant or anti-anxiety drugs. 
3: High education = university undergraduate degree or higher 
Low education = Trade school, community college, or no post-secondary education. 
4: ACE = Adverse Childhood Experiences questionnaire. 
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Table 3.6 represents the differences in self-report measures of stress as measured by 
Traumatic Injuries Distress Scale (TIDS) following traumatic musculoskeletal injury when 
the sample is split according to age, sex, BMI, education level, income level, medication 
usage, and adverse childhood experiences. Those with income ≤ CDN $100,000 total 
household per year scored higher on the negative affect subscale than those with income 
>$100,000 (t (72) =2.19; p =0.03). Those taking medications for anxiety or depression 
scored higher on the total TIDS score: t (72) = -3.47; p <0.01, the uncontrolled pain: t (72) 
= -3.05; p <0.01and negative affect: t (73) = -3.24; p <0.01 subscales. Those with lower 
education scored higher on the total score: t (62) = 2.56; p =0.01, negative affect subscale: 
t (55) = 2.53; p =0.01 and hyper arousal subscale: t (52) = 2.97; p < 0.01. 
 
Table 3.6: Mean (SD) of scores of the Traumatic Injuries Distress Scale (TIDS) scale 
and subscales Split by key personal-level variables in the acute setting of pain. 
 
Variable Total Uncontrolled 
pain Subscale 
Negative 
Affect 
Subscale 
Hyper 
arousal 
Subscale 
Age         40 or under (n = 36) 
Over 40 (n = 35) 
5.8 (4.1) 
5.8 (4.3) 
2.9 (2.0) 
3.1 (2.4) 
2.8 (2.5) 
2.6 (2.2) 
0.4 (0.7) 
0.2 (0.5) 
Sex Male (n = 25) 
Female (n = 45) 
5.5 (4.3) 
5.9 (4.1) 
2.6 (1.9) 
3.1 (2.3) 
2.7 (2.7) 
2.7 (2.1) 
0.4 (0.8) 
0.2 (0.5) 
BMI          ≤ 26.1 kg/m2 (n = 31) 
>26.1 kg/m2 (n = 30) 
6.1 (3.6) 
5.6 (4.3) 
3.2 (2.0) 
2.6 (2.1) 
2.7 (2.0) 
2.8 (2.7) 
0.2 (0.4) 
0.4 (0.8) 
Income1Group 1  (n = 52) 
Group 2  (n = 22) 
6.4 (4.2) 
4.9 (3.5) 
3.1(2.1) 
2.8 (2.1) 
3.2 (2.5) 
1.9 (1.8) 
0.3(0.7) 
0.3(0.6) 
Medication2No (n = 48) 
Yes (n = 27) 
4.8(3.8) 
7.9(3.7) 
2.4(1.9) 
3.9(2.1) 
2.2 (2.2) 
3.9 (2.1) 
0.3(0.6) 
0.3(0.6) 
Education3 Low (n = 37) 
High (n = 38) 
7.1 (4.6) 
4.7 (3.0) 
3.3 (2.2) 
2.6 (1.9) 
3.4(2.8) 
2.1(1.5) 
0.5 (0.8) 
0.1 (0.4) 
ACE4None (n = 22) 
At least 1 (n = 52)  
4.7 (3.8) 
6.5 (4.0) 
2.4 (2.2) 
3.2 (2.0) 
2.3 (1.9) 
3.0 (2.5) 
0.3 (0.6) 
0.3(0.7) 
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Bold: Differences between groups significant at the p < 0.05 level 
Italic: Differences between groups significant at the p < 0.01 level 
. 1.  Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year 
Income Group 2= > CDN$100,000 total household per year 
2: Medications considered were anti-depressant or anti-anxiety drugs. 
3: High education = university undergraduate degree or higher 
Low education = Trade school, community college, or no post-secondary education. 
4: ACE = Adverse Childhood Experiences questionnaire. 
 
 
3.1.2.2 Hypothesis 2: Exploring the correlations between stress markers 
following acute musculoskeletal injury  
Table 3.7 provides correlations between biological and psychological markers of stress 
following an acute stressful event. The association between cortisol and different self-
report measures of stress were significant at the p < 0.05 level (table 7). Cortisol showed 
significant correlations with ASDS- total scores, ASDS- distress sub scale, BPI-pain 
intensity, BPI- pain interference, BPI- affective and sleep interference sub scale scores and 
TIDS- hyper arousal scores. BDNF was correlated negatively with BPI-physical 
interference subscale scores. TGFB1 showed no significant correlations with the provided 
scale scores in the acute setting of pain. 
In the next step, Hierarchical regression was performed to assess the ability of self-report 
measures of stress to predict the variance in cortisol and BDNF after controlling for BMI. 
BMI was used as a continuous variable here. Table 3.8 contains the regression results. BPI- 
pain intensity scores and TIDS- hyper arousal scores explained 13% and 8% variance in 
cortisol respectively after controlling for BMI. 7% of the variance of BDNF was explained 
by BPI-physical interference scale score after controlling the confounding effects of BMI. 
  
54 
 
 
 
Table 3.7: Simple bivariate associations between key independent variables and 
stress biomarkers in the acute stage of injury. 
 
Bold: Correlation is significant at the p < 0.05 level 
Italic: Correlation is significant at the p < 0.01 level 
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic injuries distress 
scale. 
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed. 
2: Spearman's Rho (rho) is performed as the data are not normally distributed. 
 
Table 3.8: Percentage of variance of cortisol and BDNF explained by self-reported 
stress scores after controlling for BMI. 
DV IV R2 ∆r2 F ∆F p (change in 
F) 
Cortisol  ASDS- total score 0.09 0.04 2.62 2.10 0.15 
Cortisol  ASDS- distress 0.10 0.05 2.62 2.42 0.12 
Cortisol BPI - pain intensity 0.17 0.13 1.92 7.33 <0.01 
Cortisol BPI- pain interference 0.08 0.05 2.02 2.47 0.12 
Cortisol BPI- affective interference 0.08 0.04 2.05 1.99 0.16 
Cortisol BPI- sleep interference 0.08 0.04 2.06 2.45 0.12 
Cortisol  TIDS- hyper arousal 0.11 0.08 1.82 4.81 0.03 
BDNF  BPI - physical interference 0.13 0.07 3.36 4.14 0.04 
 
Cortisol  (pg/mL) 
 
BDNF  (pg/mL) TGFB1 (pg/mL) 
 r (p) 95% CI r (p) 95% CI r (p) 95% CI 
ASDS-total subscale1 0.26 (0.04) 0.03 to 0.45 -0.19 (0.14) -0.38 to 0.03 0.03 (0.83) -0.24 to 0.28 
ASDS-distress 
 subscale1 
0.28(0.03) 0.05 to 0.49 -0.19(0.13) -0.41 to 0.02 0.02 (0.87) -0.23 to 0.26 
ASDS-dissociation 
subscale2 
0.13(0.30) -0.13 to 0.37 -0.10 (0.41) -0.31 to 0.10 0.20 (0.87) -0.23 to 0.26 
BPI-pain intensity  
subscale1 
0.34(<0.01) 0.15 to 0.51 -0.03 (0.81) -0.26 to 0.22 0.07 (0.60) -0.17 to 0.31 
BPI-pain interference  
subscale1 
0.28(0.02) 0.08 to 0.46 -0.14 (0.27) -0.34 to 0.07 0.01 (0.94) -0.25 to 0.27 
BPI-physical 
interference subscale1 
0.24 (0.06) 0.02 to 0.44 -0.25 (0.04) -0.45 to -0.03 0.01 (0.96) -0.22 to 0.23 
BPI-affective 
interference subscale1 
0.26(0.03) 0.08 to 0.46 -0.13(0.31) -0.36 to 0.09 - 0.05 (0.69) -0.28 to 0.19 
BPI-sleep 
interference  
subscale2 
0.26(0.03) 0.03 to 0.47 -0.03 (0.80) -0.28 to 0.23 0.07 (0.56) -0.21 to 0.34 
TIDS-total score 
subscale2 
-0.13 (0.30) -0.37 to 0.13 0.01 (0.89) -0.21 to 0.24 0.12 (0.34) -0.12 to 0.34 
TIDS-uncontrolled 
pain subscale2 
0.09 (0.94) -0.26 to 0.24 -0.02 (0.86) -0.24 to 0.21  0.16 (0.19) -0.06 to 0.38 
TIDS- negative affect 
subscale2 
-0.15 (0.21) -0.43 to 0.13 0.03 (0.78) -0.19 to 0.26 0.03 (0.78) -0.20 to 0.25 
TIDS- hyper arousal 
subscale2 
-0.26 (0.03) -0.49 to -0.01 0.15 (0.21) -0.10 to 0.40 0.17 (0.17) -0.07 to 0.39 
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3.1.2.3 Hypothesis 3: Exploring the moderating effects of adverse 
childhood experiences on the correlations between biological 
and psychological variables in the acute pain setting. 
The data were split according to adverse childhood experience endorsements into ACE and 
NO ACE groups to explore potential differences in the magnitude and direction of 
correlations between self-report tools and biomarkers of stress. There were differences in 
the patterns of significant associations between the two groups. In the ACE group cortisol 
showed significant positive correlations with BPI- pain intensity (r= 0.36), pain 
interference (r = 0.36), physical interference (r = 0.35) and affective interference scores (r 
= 0.31). In contrast, people who belong to no ACE group did not show such associations. 
BDNF also showed significant negative associations with ASDS- total scores (r = -0.29) 
and distress scores (r = -0.31) in ACE group only but not in the NO ACE group. The 
associations between cortisol and ASDS- total scores (r =0.47) and distress (r = 0.49) were 
significant in the NO ACE group only. BPI- sleep interference sub scale scores are 
positively correlated with Cortisol (r = 0.53) and TGFB1 (r= 0.46) in the NO ACE group 
only. The differences in correlation coefficient were significantly different between groups 
in the cortisol x BPI Physical Interference, cortisol x BPI Affective interference, and 
cortisol x BPI sleep interference, BDNF x ASDS- total, BDNF x ASDS- distress, TGFB1 
x  BPI sleep interference evaluations by virtue of point estimates for one group that lay 
outside the 95% CI of the other group. 
56 
 
 
 
All the significant associations are plotted in scatter plots to visualize the patterns of 
associations between biological and psychological markers of stress in ACE and No ACE 
group (Figures 3.1 to 3.9).   
Table 3.9, 3.10 and 3.11 include the correlations between cortisol, BDNF, TGFB1 and self-
reported measures of stress in the acute pain setting when the data is split according to the 
history of adverse childhood effects. 
Table 3.9: Simple bivariate associations between key independent variables and 
cortisol in the acute stage of injury when the sample is split into two groups 
according to the history of childhood adversities. 
 ACE (n=44) NO ACE(n=19) 
 Cortisol (pg/ml) 
r(p) 
95 % CI Cortisol (pg/ml) 
r(P) 
95% CI 
ASDS-total1 0.23(0.15) -0.07 to 0.48  0.47* (0.05) -0.10 to 0.81 
ASDS- distress1 0.25 (0.12) -0.05 to 0.53 0.49*(0.04) -0.02 to 0.79 
ASDS 
dissociation1 
0.17 (0.28) -0.15 to 0.49 0.29 (0.22) -0.18 to 0.67 
BPI- pain intensity1 0.36*( 0.02) 
 
0.16 to 0.56 0.28(0.25) 
 
-0.13 to 0.61 
BPI-pain 
interference1 
0.36 *(0.02) 0.12 to 0.46 0.14 (0.57) 
 
-0.34 to 0.50 
Physical 
interference 
subscale1 
0.35*( 0.02) 
 
0.08 to 0.57 0.01(0.96) 
 
-0.50 to 0.41 
Affective 
interference 
subscale1 
0.31* (0.04) 
 
0.07 to 0.51 0.06(0.79) -0.35 to 0.48 
Sleep interference 
subscale2 
0.19(0.21) 
 
-0.09 to 0.46 0.53* (0.02) 
 
0.11 to 0.78 
TIDS total score2 -0.12 ( 0.45) -0.37 to 0.18 -0.13 (0.57) -0.61 to 0.26 
Negative affect2 -0.17 (0.25) -0.44 to 0.14 -0.24 (0.29) -0.67 to 0.22 
Uncontrolled pain2 0.02 (0.90) -0.26 to 0.31 -0.01 (0.98) -0.52 to 0.47 
Hyperarousal2 -0.23 (0.12) -0.47 to 0.09 -0.29 (0.19) -0.64 to 0.17 
 
Bold: Correlation is significant at the p ≤ 0.05 level 
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress 
Scale.  
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed. 
2: Spearman's Rho (rho) is performed as the data are not normally distributed. 
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Figure 3.1: Scatter plot showing the linear relationships between plasma cortisol 
and BPI-pain interference sub scale scores in ACE group and No ACE group. The 
correlation between biological and psychological markers of stress is significant at 
the p <0.05 level in ACE group. 
 
Figure 3.2: Scatter plot showing the linear relationships between plasma cortisol  
and BPI-physical interference sub scale scores in ACE group  and No ACE group  
.The correlation between biological and psychological markers of stress is 
significant at the p <0.05 level in ACE  group. 
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Figure 3.3: Scatter plot showing the linear relationships between plasma cortisol 
and BPI-Affective interference sub scale scores in ACE group and No ACE group. 
The correlation between biological and psychological markers of stress is significant 
at the p <0.05 level in ACE group. 
 
Figure 3.4: Scatter plot showing the linear relationships between plasma cortisol 
and BPI-sleep interference sub scale scores in ACE group and No ACE group. The 
correlation between biological and psychological markers of stress is significant at 
the p <0.05 level in No ACE group. 
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Figure 3.5:  Scatter plot showing the linear relationships between plasma cortisol 
and ASDS scale scores (total) in ACE group and No ACE group. The correlation 
between biological and psychological markers of stress is significant at the p ≤ 0.05 
level in No ACE group. 
 
Figure 3.6: Scatter plot showing the linear relationships between plasma cortisol 
and ASDS distress sub scale in ACE group and No ACE group. The correlation 
between biological and psychological markers of stress is significant at the p <0.05 
level in No ACE group. 
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Table 3.10: Simple bivariate associations between key independent variables and 
BDNF in the acute stage of injury when the sample is split into two groups 
according to the history of childhood adversities. 
 
Bold: Correlation is significant at the p < 0.05 level 
Italic: Correlation is significant at the p < 0.01 level 
BDNF: Brain Derived Neurotrophic Factor.  
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress 
Scale. 
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed. 
2: Spearman's Rho (rho) is performed as the data are not normally distributed. 
 ACE (n=46) NO ACE(n=18) 
 
BDNF(pg/ml) 
r(p) 
95 % CI 
BDNF(pg/ml) 
r(P) 
95% CI 
ASDS-total1 -0.29 (0.04) -0.51  to -0.01 0.08 (0.75) -0.27 to 0.48 
ASDS- 
distress1 
-0.31 (0.04) -0.49  to -0.04 0.06 (0.81) -0.29 to 0.47 
ASDS 
dissociation1 
-0.19 (0.19) -0.48 to 0.11 0.25 (0.31) -0.31 to 0.81 
BPI- pain 
intensity1 
-0.03 (0.84) -0.35 to 0.27 -0.01 (0.98) -0.44 to 0.49 
BPI-pain 
interference1 
-0.13 (0.39) -0.41 to 0.14 -0.17 (0.50) -0.53 to 0.18 
Physical 
interference 
subscale1 
-0.19 (0.19) -0.42 to 0.03 -0.31 (0.21) -0.62 to 0.03 
Affective 
interference 
subscale1 
-0.16 (0.29) -0.45 to 0.15 -0.05 (0.85) -0.46 to 0.36 
Sleep 
interference 
subscale2 
-0.12 (0.44) -0.39 to 0.24 0.08 (0.75) -0.25 to 0.45 
TIDS total 
score2 
0.08 (0.58) -0.17 to 0.34 -0.39 (0.10) -0.82 to 0.17 
Negative 
affect2 
0.09 (0.51) -0.18 to 0.34 -0.29 (0.28) -0.81 to 0.28 
Uncontrolled 
pain2 
0.01 (0.92) -0.24 to 0.26 -0.35 (0.15) -0.76 to 0.27 
Hyperarousal2 0.21 (0.14) -0.08 to 0.47 -0.04 (0.86) -0.57 to 0.49 
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Figure 3.7: Scatter plot showing the linear relationships between plasma BDNF and 
ASDS total score   in ACE group and No ACE group. The correlation between 
biological and psychological markers of stress is significant at the p <0.05 level in 
ACE group. 
 
Figure 3.8: Scatter plot showing the linear relationships between plasma BDNF  and 
ASDS -distress sub scale scores  in ACE group  and No ACE group  .The correlation 
between  biological and psychological markers of stress is significant at the p <0.05 
level in  ACE  group. 
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Table 3.11: Simple bivariate associations between key independent variables and 
TGFB1 in the acute stage of injury when the sample is split into two groups 
according to the history of childhood adversities. 
 
Bold: Correlation is significant at the p ≤ 0.05 level 
TGFB1: Transforming Growth Factor Beta 1. 
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress 
Scale. 
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed. 
2: Spearman's Rho (rho) is performed as the data are not normally distributed. 
 ACE (n=45) NO ACE(n=18) 
 TGFB1(pg/ml) 
r(p) 
95 % CI TGFB1(pg/ml) 
r(p) 
95% CI 
ASDS-total1 -0.09 (0.56) -0.36 to 0.16  0.37 (0.16) -0.39 to 0.81 
ASDS- 
distress1 
-0.10 (0.50) -0.36 to 0.15 0.31 (0.13) -0.42 to 0.78 
ASDS 
dissociation1 
-0.02 (0.86) -0.27 to 0.19  0.18 (0.46) -0.65 to 0.69 
BPI- pain 
intensity1 
0.03 (0.87) -0.27 to 0.32 0.18 (0.47) -0.29 to 0.63 
BPI-pain 
interference1 
-0.05 (0.71) -0.36 to 0.24 0.19 (0.43) -0.22 to 0.56 
Physical 
interference 
subscale1 
-0.07 (0.62) -0.34 to 0.20 0.19 (0.43) -0.15 to 0.57 
Affective 
interference 
subscale1 
-0.08 (0.58) -0.35 to 0.20  0.06 (0.79) -0.44 to 0.47 
Sleep 
interference 
subscale2 
-0.02 (0.91) -0.34 to 0.30  0.46 (0.05) -0.06 to 0.77 
TIDS total 
score2 
0.12 (0.41) -0.14 to 0.37 0.22 (0.38) -0.35 to 0.70 
Negative 
affect2 
0.04 (0.78) -0.24 to 0.31 0.15 (0.56) -0.36 to 0.61 
Uncontrolled 
pain2 
0.16 (0.28) -0.13 to 0.41 0.28 (0.25) -0.28 to 0.71 
Hyperarousal2 0.18 (0.22) -0.12 to 0.46 0.28 (0.25) -0.29 to 0.71 
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Figure 3.9: Scatter plot showing the linear relationships between plasma TGFB1 
and BPI -sleep interference sub scale scores in ACE group and No ACE group. The 
correlation between biological and psychological markers of stress is significant at 
the level p ≤ 0.05 in No ACE group. 
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3.2 Discussions 
This study examined the role of stress biomarkers in acutely traumatized patients to identify 
the major stress markers that have the potential to serve as an intervention target to prevent 
the development of chronic pain. The magnitude and direction of associations of cortisol 
and BDNF with self-reported stress markers provided supportive evidence to support 
further exploration of cortisol and BDNF as acute stress biomarkers. However, these results 
need replication. The influence of the demographic variables on the acute stress markers 
was investigated. It was found that BMI, education, income and medication usage were all 
associated with the level of different stress markers (both biological and psychological). 
The results of the study also supported a moderating role of adverse childhood experiences 
on the relationships between biological and psychological stress markers following acute 
trauma.  
All of the major findings of the current study are discussed in the following section in 
context of the existing literature. 
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3.2.1 Demographic factors (age, sex, BMI, education, income level, 
medication usage) that influence the level of stress following 
acute non catastrophic musculoskeletal trauma. 
3.2.1.1 Stress biomarkers and demographics 
The current study found no significant differences in stress biomarkers between high and 
low age groups. This finding is consistent  with  previous studies that  reported no 
differences in salivary and urinary cortisol levels between different age groups (Ceccato et 
al., 2015; Ceccato et al., 2014).  However, some other studies reported significant 
associations between older age and stress biomarkers. They reported increased level of  
salivary cortisol level (Nicolson, Storms, Ponds, & Sulon, 1997) and decreased level of 
plasma BDNF  in older age  groups (Lommatzsch et al., 2017). It has also been showed 
that serum TGFB1 level was higher in low age groups in compared to adults (Okamoto et 
al., 2005).It is worth noting that, in all these cases the differences in stress biomarkers level 
between age groups were evaluated in healthy people. To the best of our knowledge, no 
other studies have evaluated the age related differences in stress biomarkers in people who 
survived a non-catastrophic musculoskeletal injury. Previous researchers have 
recommended that in order to find the age related differences in cortisol level, it is 
necessary to include participants who are more than 70 years of age in the sample (Nicolson 
et al., 1997; Sapolsky & Plotsky, 1990). Due to the nature of the data, the present study 
used 40 as a cut off score for age groups and the age range of this sample was 18 to 66 
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years. This could be a reason for which no differences in stress markers between two age 
groups were observed in the present study.  
Many previous studies included the differences in stress biomarkers between males and 
females (Larsson, Gullberg, Råstam, & Lindblad, 2009; Kajantie & Phillips, 2006). This 
is in contrast with the current study that found no significant differences in any stress 
biomarkers between males and females. However, the result was consistent with the study 
that reported no significant differences in salivary cortisol level in males and females of 
different age groups (Nicolson et al., 1997). Another study found no significant differences 
in plasma BDNF level between males and females (Lommatzsch et al., 2017). According 
to Paris and colleagues, the differences in cortisol level in males and females following 
acute stressful condition depends on the types of the stress exposure (Paris et al., 2011). He 
found higher cortisol level in men who survived a motor vehicle collision in comparison 
to their female counterparts. On the other hand, in response to stressor like noise exposure 
women showed higher cortisol level than men. 
 There were significant differences in biological markers (cortisol and BDNF) when the 
sample was split by BMI. Previous studies have reported lower level of cortisol in obese 
people (Odeniyi, Fasanmade, Ogbera, & Ohwovoriole, 2015 ; Travison T O’Donnell A 
Araujo A Matsumoto A McKinlay J, 2007 ; Champaneri et al., 2013; Walker, Soderberg, 
Lindahl, & Olsson, 2000). Travison et al. (2007) found a negative association between 
cortisol concentration and all of their body composition parameters. This is consistent with 
the findings of the present study. In contrast, the level of  plasma BDNF was higher in the 
high BMI group compared to the low BMI group which is supported by several other 
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studies (Pillai et al., 2012; Liu et al., 2016; Fang et al., 2016). Many previous studies have 
explored BDNF and BMI in people with major depressive disorder, Schizophrenia and 
other mood disorders (Pillai et al., 2012). To the best of our knowledge, this is the first time 
the level of BDNF was explored in high and low BMI people following a traumatic 
musculoskeletal injury.  
3.2.1.2 Psychological stress markers and demographics 
The current study added to a growing body of literature that suggests "socioeconomic 
status" as one of the non -modifiable risk factors for the development of chronic pain 
conditions (van Hecke, Torrance, & Smith, 2013; Blyth, 2008; Poleshuck & Green, 2008). 
Self-reported measures of stress were different in groups split according to the education 
and income level of participants. The low education group reported greater pain intensity 
after having a traumatic event. The level of overall acute distress as measured by TIDS 
total score following trauma was also higher in the low education group. Several studies 
reported the possible role of  low education status in the development of chronic conditions 
(Udom, Janwantanakul, & Kanlayanaphotporn, 2016 ; van Hecke et al., 2013;  Dionne, 
2001). To date however the mechanism has been unclear. This current study at least sheds 
some light on this question, suggesting that lower education may lead to greater traumatic 
distress. 
The same pattern of result was also observed in people with income ≤ CDN$100,000 total 
household per year. The mean score of this income group was higher on the Negative 
Affect subscale of the TIDS compared to those with income > CDN $100,000 total 
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household per year, which is indicative of more detachment or depressive symptoms. This 
finding is consistent with other studies that also reported  the role of perceived income 
inadequacy  as one of the causative factors in the development of chronic pain (Jordan, 
Thomas, Peat, Wilkie, & Croft, 2008). According to the results of the current study, people 
with income ≤ CDN$100,000 total household per year and comparatively low education 
level report greater post-traumatic distress, which in turn may predispose them to greater 
risk of chronic pain. 
The presence of psychological co-morbidities such as depression and anxiety with chronic 
pain conditions is well established by research (Holmes, Christelis, & Arnold, 2013; Banks, 
Sara M.; Kerns, 1996; Hu et al., 2007) . However, the acute stress reaction in people who 
have already diagnosed with depression or anxiety has not been explored to our knowledge. 
This study hypothesized greater level of perceived stress in people who had depression or 
anxiety disorders at the time of the traumatic event based on the findings of previous 
research (Clauw & Chrousos, 1997; Breslau, GC, Andreski, & Peterson, 1991). The 
findings of the study supported the hypothesis.  Participants who self-reported current use 
of anti- anxiety or anti- depressant drugs had  higher level of overall distress, a lower sense 
of pain control, and greater affective impairment as obtained by TIDS- total scale scores, 
Negative affect sub scale scores and Uncontrolled pain subscale scores in comparison with 
the scores of people  who did not provide such medication history. While the mechanisms 
are unclear from this study, these results suggest that it will be important to control for pre-
existing psychological comorbidity in future studies of trauma, stress and pain. 
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3.2.2 Potential stress biomarkers and their associations with self-
report measures of stress  
The current study investigated the relationships between perceived stress and biomarkers 
of stress in people who experienced a non-catastrophic musculoskeletal injury. The 
positive correlations of cortisol with self-reported post traumatic distress can be considered 
as supportive evidence for cortisol as an acute stress biomarker. Self-reported 
psychological distress, perceived pain intensity and disabilities associated with pain 
showed statistically significant positive associations with cortisol.  
The current study found that self-reported pain intensity score predicted 13% of the 
variance in cortisol after controlling for the confounding effects of demographic variable ( 
p<0.01). Walton et al. (2013b) found a significant positive correlation between pain 
catastrophizing and hair normalized salivary cortisol in participants who underwent a 
traumatic injury. Positive associations between salivary cortisol and heightened pain 
intensity/pain catastrophizing were also evident in the experimental pain setting (Quartana 
et al., 2010Jones, Rollman, & Brooke, 1997). Perceived high pain intensity in the 
immediate aftermath of trauma has been suggested as one of the consistent predictors of 
chronic pain development (Walton et al., 2013a; Quartana, Campbell, & Edwards, 2009; 
Bortsov et al., 2014). As cortisol showed positive relation with higher pain intensity and 
previous research supported the idea that the stress system is capable of influencing pain 
processing (McLean et al., 2005); regulation of cortisol following trauma may hold 
promise as an intervention target to prevent the development of chronic conditions. 
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However, this relationship should be investigated further to reach any definitive conclusion 
considering the limited sample size and cross-sectional nature of the study. 
In the current study, self-reported hyper arousal subscale score predicted 8% of the 
variance in cortisol after controlling for the confounding effects of demographic variable 
(p < 0.05). Hyper arousal is referred to as a state which is characterized by difficulty to fall 
asleep and wakefulness because of enhanced  physical, emotional and cognitive arousal 
(Kay & Buysse, 2017).Hyper arousal after trauma was suggested as a strong indicator of 
chronic conditions like Post traumatic stress disorder (PTSD) , Whiplash associated 
disorder(WAD) and Chronic pain (Andersen, Elklit, & Vase, 2011; Liedl & Knaevelsrud, 
2008 ; Liedl et al., 2010). It has been demonstrated by a longitudinal study that the people 
who identified "acute hyper arousal " as a prominent symptom following a traumatic event 
are more likely develop chronic PTSD symptoms than who included hyper arousal as a less 
prominent one (Schell, T. L., Marshall, G. N., & Jaycox, 2004). Interestingly, PTSD and 
recovery from trauma also appeared to be dependent on each other (Sterling, Hendrikz, & 
Kenardy, 2010). Further longitudinal studies are necessary to elucidate the mechanism of 
associations between hyper arousal and the PTSD and their subsequent role in the 
development of chronic pain.  
One of the new additions of this study was to explore BDNF as an acute stress marker after 
a traumatic event. BDNF showed significant negative association with physical 
interference subscale score. In this study, self-reported physical disability as a result of 
trauma explained 7% of the variance in BDNF after controlling for the confounding effects 
of demographic variable (p < 0.05). It has been reasonably well established that exercise 
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and  physical activity can lead to increased BDNF levels in the brain (Vaynman, Ying, & 
Gomez-Pinilla, 2004; Ding et al., 2004; Schmolesky, Webb, & Hansen, 2013) that has 
potentially important neuroprotective function. According to Nijs and colleagues , high 
BDNF level may reduce the likelihood of chronic pain development due to its crucial role 
against maladaptive neuroplasticity which is the reason underlying many chronic pain 
conditions (Nijs et al., 2015). The current study suggests an association between self-rated 
interference in physical function and plasma BDNF level, but the clinical importance of 
this association requires further exploration. 
The current study also explored the role of TGFB1 as an acute stress biomarker. TGFB1 
was found not to be associated with any of the self-reported values. This is in contrast to 
previous findings. Previous studies regarded TGFB1 as potential biomarker for conditions 
like temporomandibular joint tenderness and osteoarthritis(Slade et al., 2011;Shen, Li, & 
Chen, 2014). However no studies had investigated the role of TGFB1 in the acute pain 
condition. It is probable that the role of TGFB1 may become more prevalent in chronic 
pain conditions rather than in the acute pain setting. This relationship should be explored 
further to reach a definitive conclusion.  
3.2.3 The moderating role of adverse childhood experiences on the 
associations between biological and psychological indictors of 
stress in the acute pain setting 
Considerable amount of research studies have focused on the effects of adverse childhood 
experiences as it has emerged as an important indicator of adult health and well-being(De 
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Bellis & Zisk, 2014; Vincent J Felitti & Anda, 2010). The current study investigated the 
role of adverse childhood experiences (ACE) in the acute pain setting to understand its 
interplay with other stress markers in acute pain and distress.   
People who have endorsed at least one component of the ACE scale were considered as 
the “ACE group” in this study. In the ACE group, cortisol showed significant positive 
correlations with the BPI pain intensity score and almost all of the subscale scores of BPI. 
Previous studies  reported a relationship between  heightened perceived pain intensity and 
childhood adversities (Drevin et al., 2015; Sansone,Watts, & Wiederman, 2013).Existing 
evidence suggests that the most consistent predictors of chronic pain development are high 
initial pain intensity, self-reported psychological distress and activity interference(Walton 
et al., 2013a ; McLean et al., 2005).  It is noteworthy that all of these variables (as measured 
by BPI- pain intensity subscale, physical and affective interference subscale) were 
positively correlated with cortisol only in the people who endorsed adverse childhood 
experiences. This association maybe partially explained by the dysregulation of biological 
stress system in people with ACE. Earlier research  suggested that early life adversity 
increases endocrine and  autonomic responses to stress (Anacker, O’Donnell, & Meaney, 
2014). It has also been proposed that childhood adversities lead to persistent HPA axis 
dysregulation via an epigenetic mechanism (McGowan, 2013) that may preferentially 
influence the stress-response pathways. Therefore it can be proposed that people who 
experienced childhood adversities may react to subsequent stressful events differently than 
those with no such exposure, likely due to a complex interplay of both psychological and 
physiological processes. However, this result should be interpreted with caution because 
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of the limited sample size, exploratory, cross-sectional nature of the study and retrospective 
measure of the adverse childhood experiences.  
BDNF was negatively correlated with ASDS- total score and ASDS- distress subscale 
score in the ACE group only. People who develop acute stress disorder following a 
traumatic event are more likely to develop PTSD in later life(Harvey & Bryant, 2002). 
From the results of the current study, high BDNF may protect against acute stress disorder, 
or acute stress disorder may lower levels of BDNF. Lower BDNF level was associated with 
higher ASDS scores only in the subsample who had history of adverse childhood 
experiences. This is in line with the  studies that suggested  the stressful childhood 
experiences can reduce the BDNF level in a subset of the population (Vollmayr, Faust, 
Lewicka, & Henn, 2001; Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz, 2015). 
Lower BDNF level has also been implicated in the development of several chronic 
conditions such as depression, bipolar disorder, chronic widespread pain (Elzinga et al., 
2011; Fernandes et al., 2015 ; Caumo et al., 2016). It has been shown that direct infusion 
of BDNF resulted in improvement of symptoms despite of high level of circulating 
corticosterone in a study that investigated stressed rodents (Lakshminarasimhan & 
Chattarji, 2012). These findings point to a possible interplay between cortisol, BDNF and 
psychologically perceived stress level in the acute pain setting that may suggest a new 
target for intervention to prevent chronic pain.  
There were only 19 people on the No ACE group, leading to wide confidence limits for 
many correlations and very few significant associations beyond ASDS- total score x 
cortisol and  ASDS- distress subscale score x cortisol. No other psychological markers 
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were related to cortisol in the no ACE group. BDNF showed no significant correlations 
with any of the stress variables. The Sleep interference subscale of the BPI was positively 
correlated with cortisol and TGFB1 in the No ACE group only. There are inconsistencies 
regarding the role of cortisol in sleep disturbances. Some studies found increased level of 
evening cortisol and increased cortisol awakening response in people with sleep 
disturbances (Kumari et al., 2009). Others reported decreased cortisol awakening response 
with sleep disturbances (Backhaus, Junghanns, & Hohagen, 2004) . This study found that 
increased plasma cortisol is associated with increased self-reported sleep disturbances but 
data on the cortisol awakening response is not yet available. Sleep disturbances are 
frequently associated with cytokines namely Interleulin-1(IL- 1) and Tumor necrosis factor 
(TNF) and it has been hypothesized that other cytokines may play a role in the development 
of sleep related maladies(Krueger, 2008). To the best of our knowledge this is the first 
study that reported an association between TGFB1 and sleep interference. The current 
study revealed that those who scored higher on the BPI sleep interference subscale had 
higher level of TGFB1. In the ACE group, cortisol and TGFB1 showed no associations 
with sleep interference scale scores. The mechanisms to explain these findings are unclear 
but it would appear that early life adversity moderates the association between self-reported 
distress and stress biomarkers that should be considered in the design of future studies in 
this area. 
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Chapter 4  
4 Conclusions and Recommendations 
This study supported the promising role of cortisol and BDNF as acute intervention targets 
following trauma for the prevention of chronic pain development. It can also be proposed 
from the results of the study that that people who experienced childhood adversities may 
react to subsequent stressful events differently than those with no such exposure, likely due 
to a complex interplay of both psychological and physiological processes which in turn 
may predispose to chronic pain development. However, several limitations of this study 
should be taken into consideration when interpreting the results. 
4.1 Limitations and future directions 
The study had a small sample size. According to my findings, if I wanted to fully explore 
the association between cortisol and negative affect in people with no adverse childhood 
experiences (correlation magnitude of 0.24), desiring 80% power and accepting a 5% alpha 
error rate, 99 subjects would be required (Faul, Erdfelder, Lang, & Buchner, 2007). 
Replicating the results using a larger sample is necessary. Generalizability of these findings 
may be limited due to the specific setting of the study along with the small sample size. 
This study only focused on the people who survived a minor traumatic event. 
As the study was cross sectional in nature, it was not able to indicate any causal 
relationship. More information is needed to reach any conclusions based on the results of 
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the study.  In the future, similar research should be conducted with follow up at a regular 
basis to determine the complex nature of the biological and psychological markers of pain.  
Childhood adverse effects were assessed retrospectively by ACE questionnaire. Though 
the ACE questionnaire is a widely used and reliable tool to diagnose early life adversities, 
the chance of memory bias is not to be ignored. Furthermore, the participants were 
categorized dichotomously. The participants who scored 1 to 8 were considered as ACE 
group. It is possible that the people who scored higher (4 to 8), perceived stressful 
conditions differently than the people who had moderate (1 to 3) childhood adverse 
experiences. Different types of maltreatment (physical, sexual and emotional abuse, 
parental separation, death of a parent in childhood) could have different influences on stress 
biomarkers that were not examined separately in the present study.  All these factors should 
be evaluated separately to find out the modifying role of childhood adversities on stress 
markers. This needs to be addressed in the future research.  
The impact of daily life stressors was not assessed in the current study. Current life stressors 
may influence the biomarkers which is a direction for additional research in the future.  
In this study, the serum cortisol level was determined in those people who presented to the 
emergency department between 10 am to 5 pm with a history of non-catastrophic 
musculoskeletal injuries. After obtaining consent, blood was drawn to measure stress 
biomarkers level. Cortisol secretion varies throughout the day. The diurnal secretion of 
cortisol and the resulting variation in serum cortisol concentration made the interpretation 
of a single cortisol value of the current study problematic. There may be variations in 
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cortisol concentration in people who showed up in the emergency department at different 
times of day. Venipuncture itself can results in the rise of cortisol level.  All these factors 
should be kept in mind while evaluating the results of the current study.  
This study used serum BDNF  level which may not be a direct measure of central BDNF 
level, although a strong correlation has been observed between central and peripheral 
BDNF level in animal studies (Karege, Schwald, & Cisse, 2002). An interesting topic for 
the future studies could be the evaluation of the correlations between central and peripheral 
BDNF level in humans.  
By considering the preliminary stage of this study, caution was taken while identifying 
outliers and removing them. It is possible that some outliers on a specific scale may 
represent an interesting subset of the population which could not be explored at this time, 
due to the limited sample size. However, the figures represented the relationships between 
stress markers (included in the result section) confirmed evenly distribution of scores. It is 
possible that few existing outliers could affect the relations dramatically. Hence, Additional 
work is warranted before interpreting the results of the study. 
4.2 Conclusions 
In summary, the current study provided tentative evidence for plasma cortisol and BDNF 
as acute stress biomarkers that appear to be associated with some aspects of post-traumatic 
pain and distress. Cortisol in particular was correlated with several perceived stress scores. 
The influence of demographic variables on both biological and psychological stress 
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markers provided supportive evidence to be considered in the design of future trauma-
related pain studies. The associations between the stress markers in people who endorsed 
a history of childhood adversities provided preliminary support for the modifying effects 
of the adverse childhood effects on individuals’ reactions to a stressful condition in 
adulthood. These findings point to a possible interplay between stress biomarkers, 
psychologically perceived stress level, demographic and socio-economic status and early 
life stress in the acute pain setting that may suggest a new target for intervention to prevent 
chronic pain. These associations need to be explored further to better understand the 
influence of acute distress on pain and the subsequent development of chronic problems.  
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